SynCell - User contributions [en]

Schmidt Sciences DevCell Project

2026-02-25T16:08:06Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop DevCells Kickoff Workshop]
* [https://devnotes.nucleus.engineering/collections-devcell-node-chicago Chicago node demonstration plans]
* [https://devnotes.nucleus.engineering/collections-devcell-node-london London node demonstration plans]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
[[Starts::>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Past events ===

The following events had activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
[[Starts::<{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-25T16:07:42Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop DevCells Kickoff Workshop]
* [https://devnotes.nucleus.engineering/collections-devcell-node-chicago Chicago node demonstration plans]
* [https://devnotes.nucleus.engineering/collections-devcell-node-london London node demonstration plans]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
[[Starts::<{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Past events ===

The following events had activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
[[Starts::>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-25T16:06:48Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop DevCells Kickoff Workshop]
* [https://devnotes.nucleus.engineering/collections-devcell-node-chicago Chicago node demonstration plans]
* [https://devnotes.nucleus.engineering/collections-devcell-node-london London node demonstration plans]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}
|?Location=
|format=ul
|sort=Starts
}}

=== Past events ===

The following events had activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-25T16:06:08Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop DevCells Kickoff Workshop]
* [https://devnotes.nucleus.engineering/collections-devcell-node-chicago Chicago node demonstration plans]
* [https://devnotes.nucleus.engineering/collections-devcell-node-london London node demonstration plans]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts<>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}
|?Location=
|format=ul
|sort=Starts
}}

=== Past events ===

The following events had activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts>>{{CURRENTYEAR}}/{{CURRENTMONTH}}/{{CURRENTDAY}}
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-01T23:35:44Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop DevCells Kickoff Workshop]
* [https://devnotes.nucleus.engineering/collections-devcell-node-chicago Chicago node demonstration plans]
* [https://devnotes.nucleus.engineering/collections-devcell-node-london London node demonstration plans]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-01T23:33:06Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [DevCells Kickoff Workshop https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop]
* [Chicago node demonstration plans https://devnotes.nucleus.engineering/collections-devcell-node-chicago]
* [London node demonstration plans https://devnotes.nucleus.engineering/collections-devcell-node-london]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2026-02-01T23:32:41Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

* [DevCells Kickoff Workshop https://devnotes.nucleus.engineering/articles/bnext-devnotes-devcells-kickoff-workshop)
* [Chicago node demonstration plans https://devnotes.nucleus.engineering/collections-devcell-node-chicago]
* [London node demonstration plans https://devnotes.nucleus.engineering/collections-devcell-node-london]

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.engineering Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2025-12-15T14:22:37Z

Murray: synthetic cells → developer cells

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in "developer cells", a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Developer cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of developer cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.bnext.bio Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2025-11-14T20:04:34Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Cécile Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in synthetic cells, a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Synthetic cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of synthetic cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.bnext.bio Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2025-11-10T13:49:08Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Camille Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|320px|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in synthetic cells, a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Synthetic cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of synthetic cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.bnext.bio Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Schmidt Sciences DevCell Project

2025-11-10T13:47:47Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Camille Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|link=https://www.cds.caltech.edu/~murray/talks/devcells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in synthetic cells, a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Synthetic cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of synthetic cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.bnext.bio Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

File:Murray jhu2025-firstpage.png

2025-11-10T13:45:12Z

Murray:

Schmidt Sciences DevCell Project

2025-11-09T18:14:19Z

Murray:

<center>
Developer Cells as a Scalable Platform for Predictable Engineering of (Non-Living) Biological Machines

{|
|- valign=top
| align="center" | Richard M. Murray Schmidt Sciences
| width="10%" |  
| align=center | Akshay Maheshwari    Anton Jackson-Smith    Anton Molina San Francisco (b.next)
|}


Camille Chazot    Neha Kamat    Allen Liu    Julius Lucks    Ryan Truby    Danielle Tullman-Ercek 
Chicago (Northwestern/U. Mich)



Michael Booth    Oscar Ces    Claudia Contini    Yuval Elani    James Hindley    Ravinash Krishna Kumar 
London (Imperial/King's/UCL)


</center>

[[Image:murray_jhu2025-firstpage.png|right|thumb|link=https://www.cds.caltech.edu/~murray/talks/developer_cells-jhu_11Nov2025.pdf]]
The goal of this project is to demonstrate a model for biological systems engineering that can serve as a starting point for a larger effort in systems engineering of biological systems. We are focused on proof-of-concept demonstrations in synthetic cells, a class of non-living biological machines, constructed from biological components such as lipids, amino acids, proteins, and DNA. Synthetic cells do not mutate or evolve, allowing more systematic and repeatable engineering, and also providing significant advantages in environments where it may not be desirable to deploy genetically engineered organisms. A major element of our work is the development of open source tools that help “routinize” the creation of synthetic cells. We anticipate that the methods we develop can also serve as a testbed for engineering methods in living organisms.

=== Upcoming events ===

The following events will have activities related to the developer cell project. Additional information can be found by following the link.

{{#ask:
[[Category:Events]]
|?Starts=
|?Location=
|format=ul
|sort=Starts
}}

=== Links to additional resources ===

* [https://github.com/BuildACell/bioCRNpyler BioCRNpyler] - Biomolecular chemical reaction network compiler
* [https://github.com/biocircuits/bioscrape BioSCRAPE] - Biological stochastic simulation of single cell reactions and parameter estimation
* [https://www.buildacell.org Build-A-Cell] - Open collaboration supporting the science and engineering of building synthetic cells
* [https://nucleus.bnext.bio Nucleus] - Open source package for synthetic cell builders
* [https://github.com/martinez-zacharya/TRILL TRILL] - Sandbox for creative protein engineering and discovery
* [https://vivarium-collective.github.io Vivarium ] - Simulation engine for composing and executing integrative multi-scale models

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Form:Event

2025-11-09T15:47:07Z

Murray:

<noinclude>
This is the "Event" form.
To create a page with this form, enter the page name below;
if a page with that name already exists, you will be sent to a form to edit that page.

{{#forminput:form=Event|autocomplete on category=Events}}

</noinclude><includeonly>
<div id="wikiPreview" style="display: none; padding-bottom: 25px; margin-bottom: 25px; border-bottom: 1px solid #AAAAAA;"></div>

{{{for template|Event}}}
{{{info|page name=<Title>}}}

{| class="formtable"
! Title:
| {{{field|Title}}}
|-
! Start date:
| {{{field|Starts}}}
|-
! End date:
| {{{field|Ends}}}
|-
! Location:
| {{{field|Location}}}
|-
! More info (URL):
| {{{field|URL}}}
|}
{{{end template}}}

'''Free text:'''

{{{standard input|free text|rows=10}}}
</includeonly>

SEED 2026

2025-11-09T15:45:21Z

Murray:

{{Event
|Title=SEED 2026
|Starts=2026-06-15
|Ends=2026-06-18
|Location=Denver, CO
|URL=https://synbioconference.org/2026
}}
The Synthetic Biology: Engineering, Evolution, and Design (SEED) conference is the leading technical event for synthetic biology — covering the field from its foundations to its commercial applications. Gain insight into next-generation development strategies from leaders in research and industry.

As part of SEED 2026, the [[Schmidt Sciences DevCell Project]] will host a workshop on 14 Jun (Sun).

SEED 2026

2025-11-09T15:44:46Z

Murray: Murray moved page Title to SEED 2026 without leaving a redirect

{{Event
|Title=SEED 2026
|Starts=2026-06-15
|Ends=2026-06-18
|Location=Denver, CO
|URL=https://synbioconference.org/2026
}}
SEED is the leading technical event for synthetic biology — covering the field from its foundations to its commercial applications. Gain insight into next-generation development strategies from leaders in research and industry.

As part of SEED 2026, the [[Schmidt Sciences DevCell Project]] will host a workshop on 14 Jun (Sun).

SEED 2026

2025-11-09T15:44:12Z

Murray: Created page with "{{Event |Title=SEED 2026 |Starts=2026-06-15 |Ends=2026-06-18 |Location=Denver, CO |URL=https://synbioconference.org/2026 }} SEED is the leading technical event for synthetic biology — covering the field from its foundations to its commercial applications. Gain insight into next-generation development strategies from leaders in research and industry. As part of SEED 2026, the Schmidt Sciences DevCell Project will host a workshop on 14 Jun (Sun)."

Schmidt Sciences DevCell Project

2025-11-09T15:42:10Z

Murray:

{{Consortium
|Member countries=UK, USA
|Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan
|Founded=2025-11-01
}}
The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells).

Upcoming events:
{{#ask:
[[Category:Events]]
| format=ul
}}

Schmidt Sciences DevCell Project

2025-11-09T15:40:34Z

Murray: Created page with "{{Consortium |Member countries=UK, USA |Member organizations=b.next, Imperial College London, King's College London, Northwestern University, University College London, Univerisity of Michigan |Founded=2025-11-01 }} The Schmidt Sciences Developer Cell (DevCell) project is a one year demonstration project to demonstrate the use of Developer Cells (DevCells). Upcoming events: {{#ask: Category:Events }}"

Property:Location

2025-11-09T15:35:26Z

Murray:

This is a property of type [[Has type::Text]].

The allowed value for this property is:

SynCell 2026

2025-11-09T15:33:25Z

Murray: Created page with "{{Event |Title=SynCell 2026 |Starts=2026-04-22 |Ends=2026-04-24 |Location=Institute of Physics, London |URL=https://syntheticcell.eu/events/syncell2026/ }} The SynCell conference is the only international conference on the engineering of synthetic cells and organelles. During the conference, researchers worldwide meet up and exchange news and advances in this field. Registration for this event is not yet open but will be announced on the website above. As part of t..."

{{Event
|Title=SynCell 2026
|Starts=2026-04-22
|Ends=2026-04-24
|Location=Institute of Physics, London
|URL=https://syntheticcell.eu/events/syncell2026/
}}
The SynCell conference is the only international conference on the engineering of synthetic cells and organelles. During the conference, researchers worldwide meet up and exchange news and advances in this field.

Registration for this event is not yet open but will be announced on the website above.

As part of this conference, the DevCell project will be holding a Developer Cell workshop, likely just before or just after the conference. More information will be posted as soon as registration of SynCell 2026 opens.

Form:Event

2025-11-09T15:32:44Z

Murray:

<noinclude>
This is the "Event" form.
To create a page with this form, enter the page name below;
if a page with that name already exists, you will be sent to a form to edit that page.

{{#forminput:form=Event|autocomplete on category=Events}}

</noinclude><includeonly>
<div id="wikiPreview" style="display: none; padding-bottom: 25px; margin-bottom: 25px; border-bottom: 1px solid #AAAAAA;"></div>

{{{for template|Event}}}
{{{info|page name=Title}}}

{| class="formtable"
! Title:
| {{{field|Title}}}
|-
! Start date:
| {{{field|Starts}}}
|-
! End date:
| {{{field|Ends}}}
|-
! Location:
| {{{field|Location}}}
|-
! More info (URL):
| {{{field|URL}}}
|}
{{{end template}}}

'''Free text:'''

{{{standard input|free text|rows=10}}}
</includeonly>

Form:Event

2025-11-09T15:28:28Z

Murray:

<noinclude>
This is the "Event" form.
To create a page with this form, enter the page name below;
if a page with that name already exists, you will be sent to a form to edit that page.

{{#forminput:form=Event|autocomplete on category=Events}}

</noinclude><includeonly>
<div id="wikiPreview" style="display: none; padding-bottom: 25px; margin-bottom: 25px; border-bottom: 1px solid #AAAAAA;"></div>

{{{for template|Event}}}
{{{info|page name=<Event[PageTitle]>}}}
{| class="formtable"
! Title:
| {{{field|Title}}}
|-
! Start date:
| {{{field|Starts}}}
|-
! End date:
| {{{field|Ends}}}
|-
! Location:
| {{{field|Location}}}
|-
! More info (URL):
| {{{field|URL}}}
|}
{{{end template}}}

'''Free text:'''

{{{standard input|free text|rows=10}}}
</includeonly>

Admin

2025-11-09T15:27:08Z

Murray:

{{#formlink:form=LiteratureEntry|link text=Create a new literature entry}}

{{#formlink:form=Event|link text=Create a new event entry}}

Admin

2025-11-09T15:25:49Z

Murray:

{{#formlink:form=LiteratureEntry|link text=Create a new literature entry}}

{{#formlink:form=EventEntry|link text=Create a new event entry}}

Build-A-Cell workshop, Feb 2026

2025-11-09T15:21:24Z

Murray: Murray moved page Build-A-Cell workshop to Build-A-Cell workshop, Feb 2026 without leaving a redirect

{{Event
|Title=Build-A-Cell workshop #15
|Starts=2026-02-02
|Ends=2026-02-02
|Location=University of Michigan (Ann Arbor, MI)
|URL=https://www.buildacell.org/workshop15
}}
Workshop will be on Monday, 2 February 2026, on the campus of the University of Michigan in Ann Arbor. Registration is not yet open, but will be so soon.

More information on Build-A-Cell at https://buildacell.org

Build-A-Cell workshop, Feb 2026

2025-11-09T15:19:20Z

Murray: Create event.

Property:URL

2025-11-09T15:16:31Z

Murray: Created a property of type Page

This is a property of type [[Has type::Page]].

The allowed value for this property is:

Property:Ends

2025-11-09T15:15:52Z

Murray: Created a property of type Date

This is a property of type [[Has type::Date]].

The allowed value for this property is:

Category:Events

2025-11-09T15:15:48Z

Murray:

Property:Starts

2025-11-09T15:15:36Z

Murray: Created a property of type Date

This is a property of type [[Has type::Date]].

The allowed value for this property is:

Property:Location

2025-11-09T15:15:36Z

Murray: Created a property of type Page

This is a property of type [[Has type::Page]].

The allowed value for this property is:

Admin

2025-11-09T15:15:36Z

Murray:

{{#formlink:form=LiteratureEntry|link text=Create a new literature entry}}

{{#formlink:form=Event|link text=Create a new event entry}}

Property:Title

2025-11-09T15:15:20Z

Murray: Created a property of type Text

This is a property of type [[Has type::Text]].

The allowed value for this property is:

Form:Event

2025-11-09T15:14:56Z

Murray:

<noinclude>
This is the "Event" form.
To create a page with this form, enter the page name below;
if a page with that name already exists, you will be sent to a form to edit that page.

{{#forminput:form=Event|autocomplete on category=Events}}

</noinclude><includeonly>
<div id="wikiPreview" style="display: none; padding-bottom: 25px; margin-bottom: 25px; border-bottom: 1px solid #AAAAAA;"></div>
{{{for template|Event}}}
{| class="formtable"
! Title:
| {{{field|Title}}}
|-
! Start date:
| {{{field|Starts}}}
|-
! End date:
| {{{field|Ends}}}
|-
! Location:
| {{{field|Location}}}
|-
! More info (URL):
| {{{field|URL}}}
|}
{{{end template}}}

'''Free text:'''

{{{standard input|free text|rows=10}}}
</includeonly>

Template:Event

2025-11-09T15:14:56Z

Murray:

<noinclude>
{{#template_params:Title (property=Title)|Starts (label=Start date;property=Starts)|Ends (label=End date;property=Ends)|Location (property=Location)|URL (label=More info (URL);property=URL)}}
</noinclude><includeonly>{| class="wikitable"
! Title
| [[Title::{{{Title|}}}]]
|-
! Start date
| [[Starts::{{{Starts|}}}]]
|-
! End date
| [[Ends::{{{Ends|}}}]]
|-
! Location
| [[Location::{{{Location|}}}]]
|-
! More info (URL)
| [[URL::{{{URL|}}}]]
|}

[[Category:Events]]
</includeonly>

Synthetic Cell Applications

2025-10-22T19:51:16Z

Murray:

This page contains a summary of some of the applications of synthetic cells that have been described in the literature. This page focuses on "practical" applications; the [[synthetic cell demonstrations]] page focuses on proof-of-concept demonstrations. This page was generating using the following prompt to the [https://platform.futurehouse.org FutureHouse Falcon] deep search tool:

: I would like to get an explicit description of what has and can be done with synthetic cells (benefits), distinguishing between confined-use and open-environment applications, with a view toward understanding potential risks as well. In particular, I would like to cover the following points:

: A. What has been done (doesn’t need to be a comprehensive review, but should explicitly state examples from different sectors/applications)

:: 1. Current state of synthetic cell R&D
:: 2. Applications in different sectors
:: 3. Applications in confined vs. open environments

: B. What could be done (speculative, but balanced/supported by evidence and avoiding hype) – emerging trends and future directions

:: 1. Innovation trajectories

:: 2. Democratization trajectory: falling costs may enable small‑lab or garage‑level construction; implications for oversight and surveillance.

:: 3. Drivers of R&D

:: 4. Possible points of inflection or disruption

:: 5. Potential “halo effects” — unintended positive externalities (e.g., ecosystem remediation side‑benefits).

The results were edited and rearranged by the page editors.

== Introduction ==

Synthetic cells—also known as artificial cells or protocells—are engineered membrane‐bound compartments designed to mimic one or more functions of natural cells. Such systems are typically built from defined molecular components including lipids, polymers, peptides, or even elastin‐like polypeptides, and have been constructed via bottom‑up, top‑down, or middle‑out methods <ref name="Sato2022">Synthetic cells in biomedical applications. Wakana Sato, Tomasz Zajkowski, Felix Moser, Katarzyna P. Adamala. WIREs Nanomedicine and Nanobiotechnology (2022). https://doi.org/10.1002/wnan.1761</ref>, <ref name="Rothschild2024">Building Synthetic Cells─From the Technology Infrastructure to Cellular Entities. Lynn J. Rothschild, Nils J. H. Averesch, Elizabeth A. Strychalski, Felix Moser, John I. Glass, Rolando Cruz Perez, Ibrahim O. Yekinni, Brooke Rothschild-Mancinelli, Garrett A. Roberts Kingman, Feilun Wu, Jorik Waeterschoot, Ion A. Ioannou, Michael C. Jewett, Allen P. Liu, Vincent Noireaux, Carlise Sorenson, Katarzyna P. Adamala. ACS Synthetic Biology (2024). https://doi.org/10.1021/acssynbio.3c00724</ref>. Many research groups have contributed foundational work in engineering these systems as both models for understanding life and platforms for practical applications <ref name="Rothschild2024" />, <ref name="Elani2021">Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology. Yuval Elani. Angewandte Chemie (2021). https://doi.org/10.1002/ange.202006941</ref>.

== Examples of Synthetic Cell Capabilities and Applications ==

=== Engineered Biochemical Reactors and Gene Expression Systems ===

One of the earliest and most significant achievements in synthetic cell research is the construction of cell‑sized compartments that recapitulate fundamental cellular processes such as gene expression, metabolic control, and even aspects of the cell cycle. For example, bottom‑up synthetic approaches have led to the assembly of minimal cell cycle circuits that incorporate key regulators such as cyclins and cyclin‑dependent kinases, enabling sustained biochemical oscillations within defined compartments <ref name="Groaz2021">Engineering spatiotemporal organization and dynamics in synthetic cells. Alessandro Groaz, Hossein Moghimianavval, Franco Tavella, Tobias W. Giessen, Anthony G. Vecchiarelli, Qiong Yang, Allen P. Liu. WIREs Nanomedicine and Nanobiotechnology (2021). https://doi.org/10.1002/wnan.1685</ref>. In many cases, these compartments are formed using giant unilamellar vesicles (GUVs) generated by techniques such as microfluidic synthesis, which allow for precise control over size, composition, and encapsulation efficiency <ref name="Elani2018">Constructing vesicle-based artificial cells with embedded living cells as organelle-like modules. Yuval Elani, Tatiana Trantidou, Douglas Wylie, Linda Dekker, Karen Polizzi, Robert V. Law, Oscar Ces. Scientific Reports (2018). https://doi.org/10.1038/s41598-018-22263-3</ref>, <ref name="Stano2018">Is Research on "Synthetic Cells" Moving to the Next Level?. Pasquale Stano. Life (2018). https://doi.org/10.3390/life9010003</ref>. Furthermore, cell‑free protein synthesis systems can be housed within such vesicles, enabling controlled gene expression and the production of functional proteins—a key step toward creating autonomous synthetic cells <ref name="Sato2022" />.

=== Biomedical Applications ===

Synthetic cells have been envisioned for a broad range of biomedical applications. In therapeutic contexts, they have been proposed to inhibit tumor growth by serving as microreactors that produce antimicrobial peptides or anti‑cancer proteins in response to external stimuli <ref name="Sato2022" />, <ref name="Elani2021" />. Several studies have demonstrated that synthetic vesicles can act as potential vehicles for drug delivery, wherein controlled release mechanisms—triggered by light, magnetic fields, or changes in pH—enable targeted therapies that minimize off‑target effects <ref name="Rothschild2024" />, <ref name="Elani2021" />. In addition, hybrid systems have been constructed in which living cells are encapsulated within synthetic membranes; such "embedded hybrid" configurations protect the natural cells from otherwise toxic environments while also providing additional functionalities such as bioenergetic support through photosynthetic or chromatophore‑based modules <ref name="Elani2018" />, <ref name="Elani2021" />. Researchers have also demonstrated that synthetic cells can interact with natural cells via two‑way communication pathways, indicating their potential to serve as artificial organelles or "cellular implants" that modulate biological processes such as immune responses or tissue regeneration <ref name="Groaz2021" />, <ref name="Rothschild2024" />.

=== Applications in Biosensing, Diagnostic, and Environmental Technologies ===

Synthetic cells have been developed as advanced biosensors and diagnostic platforms. Their engineered compartmentalization enables the isolation and quantification of biochemical reactions that are triggered by specific metabolites or molecular signals. For instance, constructed synthetic vesicles have been used to monitor lactate levels or detect quorum sensing signals from bacterial populations, effectively translating molecular information into detectable outputs <ref name="Smith2022">Controlling Synthetic Cell-Cell Communication. Jefferson M. Smith, Razia Chowdhry, Michael J. Booth. Frontiers in Molecular Biosciences (2022). https://doi.org/10.3389/fmolb.2021.809945</ref>, <ref name="Rothschild2024" />. In the environmental domain, synthetic cell systems are being explored to replace chemical fertilizers, tailor plant microbiomes, and improve bioremediation processes by surviving in harsh conditions and acting on synthetic compounds <ref name="Rothschild2024" />. Such platforms offer significant advantages over natural cells given their defined composition and inherent biosafety, which minimizes risks of uncontrolled proliferation in open environments <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Applications in Confined (In Vitro) vs. Open (In Vivo) Environments ===

In tightly controlled laboratory settings, synthetic cells have predominantly been utilized as model systems to dissect cellular processes under precisely defined conditions. Studies conducted using liposome‑ or polymersome‑based compartments have provided insight into enzyme kinetics, genetic circuit operation, and reaction network behaviors, often utilizing microfluidic techniques to ensure monodispersity and reproducibility <ref name="Groaz2021" />, <ref name="Stano2018" />. By contrast, application in open environments—such as for therapeutic delivery or environmental remediation—presents additional challenges that have been addressed through hybrid strategies. For example, synthetic vesicles that interface with natural cells have been tailored to exhibit robust stability and environmental responsiveness, allowing them to operate in the dynamic and less predictable conditions encountered in vivo or in nature <ref name="Elani2021" />, <ref name="Rothschild2024" />. In some cases, the integration of living cell modules within artificial cells has been exploited as a means to endow these systems with adaptive properties that are otherwise challenging to achieve in entirely synthetic constructs <ref name="Elani2018" />, <ref name="Rothschild2024" />.

=== Materials and Methodologies in Synthetic Cell Construction ===

Synthetic cell membranes themselves are engineered from a variety of materials, each with distinct advantages and limitations. Phospholipid membranes remain a widely used platform because they closely mimic natural cell membranes and are highly compatible with membrane proteins; however, their mechanical fragility can limit their application in dynamic or harsh environments <ref name="Groaz2021" />, <ref name="Rothschild2024" />. In response, researchers have increasingly employed alternative materials such as block copolymers—which produce polymersomes—and elastin‑like polypeptides (ELPs) that yield more robust synthetic membranes <ref name="Elani2021" />, <ref name="Elani2018" />. The latter systems not only demonstrate improved stability under osmotic and chemical stress but also enable dynamic remodeling of the membrane by incorporating newly expressed peptides via cell‑free expression <ref name="Elani2018" />, <ref name="Elani2021" />. These material innovations are foundational for both fundamental studies and translational applications, as they expand the operational window of synthetic cells in diverse environments.

== Potential Future Directions and Emerging Trends ==

=== Innovation Trajectories in Synthetic Cell Development ===

Emerging research trends suggest that the field of synthetic cells is poised for continual innovation toward constructing systems that display increased autonomy and complexity. One of the major future directions is the development of synthetic cells that not only encapsulate biochemical reactions but also exhibit self‑sustained processes such as growth, division, and evolution. Current efforts on minimal cell cycle circuits and feedback network systems lay the groundwork for achieving autonomous replication and self‑maintenance, with theoretical models (e.g., the "ideal synthetic cell" concept) pointing toward future realizations where the phenotype can be predicted directly from genotype <ref name="Sato2022" />, <ref name="Rothschild2024" />. This line of research is supported by experiments in which synthetic cells incorporate metabolic modules—such as those enabling light‑driven ATP synthesis or NAD regeneration—thereby providing the necessary energy for sustained biochemical activity <ref name="Groaz2021" />, <ref name="Devaraj2021">Synthesis of lipid membranes for artificial cells. Kira A. Podolsky, Neal K. Devaraj. Nature Reviews Chemistry (2021). https://doi.org/10.1038/s41570-021-00303-3</ref>. Over the next decade it is conceivable that further integration of genetic circuits with robust metabolic networks will lead to synthetic cells that can undergo controlled division cycles and adapt via evolutionary processes, offering a new paradigm for understanding the transition from chemistry to biology <ref name="Rothschild2024" />.

Beyond the reproduction of basic life processes, future synthetic cells may incorporate advanced sensing and communication capabilities that enable them to function as intelligent therapeutic systems. For instance, integration of optogenetic tools and synthetic RNA thermometers could allow spatiotemporally controlled expression of therapeutic proteins and facilitate on‑demand activation of cellular responses in vivo <ref name="Elani2021" />, <ref name="VanRaad2021">In Vitro Protein Synthesis in Semipermeable Artificial Cells. Damian Van Raad, Thomas Huber. ACS Synthetic Biology (2021). https://doi.org/10.1021/acssynbio.1c00044</ref>. Moreover, recent work on chemically programmed cell–cell communication has demonstrated that synthetic cells can be engineered to engage in two‑way information exchange with natural cells, thus paving the way for sophisticated hybrid interfaces that integrate living tissue with artificial constructs <ref name="Elani2021" />, <ref name="Smith2022" />. These advances may ultimately converge in the development of synthetic cells capable of coordinating with biological systems in a "cyber‑biological" network that responds to physiological cues with high specificity and precision <ref name="Rothschild2024" />.

=== Democratization Trajectory and the Implications for Oversight ===

An important emerging trend is the falling cost of DNA synthesis, cell‑free expression systems, and microfluidic fabrication methods, which collectively are lowering the barriers to entry for synthetic cell engineering. The rapid progress in open‑source biotechnology is democratizing access to these technologies, making it increasingly feasible for small academic labs and even decentralized "garage‑level" operations to build and experiment with synthetic cells <ref name="Sato2022" />, <ref name="Rothschild2024" />. This democratization holds great promise for accelerating innovation and fostering a more decentralized approach to discovery; however, it also raises critical issues of oversight and biosafety. The ease of constructing programmable synthetic cells may necessitate new frameworks for regulation and risk assessment to ensure that such constructs, when deployed in open environments, do not inadvertently disrupt natural ecosystems or pose security risks <ref name="Sato2022" />, <ref name="Rothschild2024" />.

One potential response to these challenges is the development of intrinsic biosafety measures, such as the integration of kill switches or "containment devices" that render synthetic cells incapable of sustained proliferation outside controlled environments <ref name="Sato2022" />, <ref name="Gobbo2020">From protocells to prototissues: a materials chemistry approach. Pierangelo Gobbo. Biochemical Society Transactions (2020). https://doi.org/10.1042/bst20200310</ref>. Moreover, the open‑source sharing of protocols and negative results—as encouraged by some in the community—could lead to more standardized safety practices and accelerated troubleshooting of potential hazards <ref name="Rothschild2024" />. In this way, the democratization of synthetic cell technology may not only spur innovation but also drive the creation of community‑based regulatory frameworks aimed at minimizing risks while ensuring positive externalities.

=== Key Drivers of Research and Development ===

Several technological and conceptual drivers are fueling rapid progress in the synthetic cell space. Foremost among these is the advancement in microfluidic platforms, which enable high‑throughput and precise generation of cell‑sized compartments with controlled composition and reproducibility <ref name="Elani2018" />, <ref name="Stano2018" />. These platforms not only permit the creation of robust vesicles but also enable intricate spatial arrangement and temporal control of biochemical reactions within synthetic cells <ref name="Rothschild2024" />.

Another crucial driver is the maturation of cell‑free protein synthesis technologies that are essential for the internal functioning of synthetic cells. The continued refinement of orthogonal translation systems and genetic code expansion techniques allows for the production of non‑canonical proteins and enzymes that may endow synthetic cells with novel functionalities not present in natural organisms <ref name="Sato2022" />. Additionally, innovations in membrane engineering—ranging from the use of natural phospholipids to robust synthetic polymers and peptide‑based membranes—are expanding the operational range and stability of synthetic cells, making them more suitable for practical applications in harsh or dynamic environments <ref name="Groaz2021" />, <ref name="Elani2018" />. These technological improvements are complemented by computational modeling and agent‑based simulations, which provide predictive frameworks for complex reaction networks and help researchers optimize synthetic cell designs prior to experimental implementation <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Points of Inflection and Potential Disruptive Moments ===

The field of synthetic cells is approaching several potential points of inflection. One such inflection point lies in achieving full self‑reproduction and autonomous cell division within synthetic constructs. Despite significant progress, most current synthetic cells require external energy inputs and careful control to sustain metabolic activities; a breakthrough in developing self‑sustaining replication would mark a dramatic shift toward fully "living" synthetic cells <ref name="Sato2022" />. Such progress could trigger a cascade of additional innovations, including open‑ended evolution, whereby synthetic cells could adapt and optimize their functions in response to environmental stimuli <ref name="Rothschild2024" />, <ref name="Devaraj2021" />.

Another potential disruption is the integration of synthetic cells with electronic and digital technologies to create hybrid bioelectronic devices. For instance, coupling synthetic cells with optogenetic control systems or nanostructured sensors could enable real‑time monitoring and precise modulation of cellular functions, opening up novel applications in diagnostics, targeted therapy, and biomanufacturing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />. Such convergence of biotechnology with information technology is likely to generate platforms that are far more responsive and adaptable than current systems.

Furthermore, the ongoing convergence between synthetic biology and materials science may lead to the development of programmable "smart" surfaces and biohybrid materials that incorporate synthetic cells as active elements. These materials could be designed to self‑heal, dynamically respond to economic or environmental stressors, or even mediate communication between disparate biological systems, thereby revolutionizing fields such as regenerative medicine, soft robotics, and environmental remediation <ref name="Rothschild2024" />.

=== Potential "Halo Effects" and Unintended Positive Externalities ===

Beyond their direct applications, synthetic cells have the potential to generate broad societal benefits that extend well beyond their immediate technological impact. For example, the development of robust synthetic cells for biomanufacturing could lead to alternative production platforms for pharmaceuticals, enzymes, and biomaterials that are more sustainable and less resource‑intensive than traditional cell‑based production methods <ref name="Sato2022" />, <ref name="Rothschild2024" />. In the environmental arena, synthetic cells designed for detoxification or pollutant sequestration could contribute to ecosystem remediation efforts by breaking down plastics, heavy metals, or organic contaminants in situ <ref name="Rothschild2024" />.

Moreover, the cross‑disciplinary innovations that underlie synthetic cell technology are likely to have "halo effects" in adjacent fields. Advances in high‑precision microfluidics and membrane engineering, for instance, are directly applicable to the fabrication of nanoscale devices and diagnostic sensors, thereby accelerating progress in nanomedicine and point‑of‑care diagnostics <ref name="Elani2018" />, <ref name="Stano2018" />. In academic settings, the relatively low cost and modularity of synthetic cell systems may inspire a new generation of bioengineers and chemists to explore the fundamentals of life in an open‑source and distributed manner, further democratizing science while fostering innovation in education and research <ref name="Sato2022" />, <ref name="Rothschild2024" />.

In addition, the ethical and regulatory discussions catalyzed by the increasing accessibility of synthetic cell technologies may lead to more robust oversight frameworks that protect public health and the environment while simultaneously encouraging safe innovation <ref name="Sato2022" />, <ref name="Rothschild2024" />. The increased emphasis on biosafety, kill switches, and built‑in containment measures—not only for synthetic cells but for related gene‑editing and synthetic biology applications—has the potential to elevate standards across the board and reduce risk in both industrial and academic settings.

== Summary and Conclusions ==

The field of synthetic cells has demonstrated significant progress across a wide spectrum of applications. Researchers have built platforms that mimic crucial features of natural cells such as compartmentalization, metabolism, gene expression, and communication. In vitro models have enabled precise investigations of biochemical processes, while hybrid systems that interface synthetic cells with natural cells have shown promise in therapeutic, diagnostic, and environmental applications <ref name="Elani2021" />, <ref name="Groaz2021" />, <ref name="Rothschild2024" />. The evolution of biomimetic membranes—from conventional phospholipid vesicles to robust elastin‑like polypeptide and polymersome systems—has broadened the operational envelope of synthetic cells, enabling their use both in controlled laboratory conditions and in more dynamic, open environments <ref name="Groaz2021" />, <ref name="Elani2018" />.

Looking forward, several key innovation trajectories are likely to transform synthetic cell technology. The drive toward achieving autonomous self‑reproduction and complex metabolic integration in synthetic cells represents perhaps the most fundamental challenge, with breakthroughs in these areas promising to create systems that effectively blur the line between non‑living engineered constructs and living organisms <ref name="Sato2022" />. Concurrently, the rapid democratization of biotechnological tools—including low‑cost DNA synthesis and robust cell‑free expression systems—is poised to make the construction of synthetic cells accessible not only to well‑funded laboratories but also to smaller research groups and possibly citizen scientists, a development that will necessitate careful oversight and updated regulatory frameworks <ref name="Rothschild2024" />.

Key drivers of current and future research include advanced microfluidic fabrication techniques, improved membrane engineering and material choices, and enhanced cell‑free systems that support sophisticated gene circuits. These tools provide the means for building increasingly intricate synthetic cells that can serve as platforms in biomedicine, environmental remediation, biomimetic robotics, and sustainable biomanufacturing <ref name="Elani2018" />, <ref name="Stano2018" />, <ref name="Sato2022" />. In addition, the integration of synthetic cells with digital and electronic control systems may give rise to hybrid bioelectronic devices that markedly improve the precision of drug delivery and diagnostic sensing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />.

Moreover, as synthetic cell technology further matures, unintended yet positive externalities are likely to emerge. The same innovations that enable the creation of minimal cell‑like systems could lead to new strategies for ecosystem remediation by deploying synthetic cells that degrade pollutants or sequester heavy metals in contaminated environments <ref name="Rothschild2024" />. In biomanufacturing, synthetic cells may provide scalable and highly controlled platforms for the production of high‑value compounds, reducing reliance on natural organisms that are often constrained by slower growth rates and more complex regulatory networks <ref name="Rothschild2024" />.

Overall, synthetic cell research is advancing along multiple convergent trajectories that are transforming both our understanding of life and the technologies that control biological processes. The integration of multidisciplinary approaches—from materials science and microfluidics to cell‑free synthetic biology and computational modeling—is fostering a rich environment for innovation. Groups such as those led by Adamala, Kamat, Booth, Elani, Liu, Deveraj, and Schwille continue to push the boundaries of what can be achieved with synthetic cells, demonstrating practical applications that span medicine, biotechnology, environmental science, and beyond <ref name="Elani2023">What it means to be alive: a synthetic cell perspective. Yuval Elani, John M. Seddon. Interface Focus (2023). https://doi.org/10.1098/rsfs.2023.0036</ref>, <ref name="Elani2021" />.

In conclusion, the current state of synthetic cell R&D is characterized by stepwise progress in creating well‑defined, functional cell‑mimics that have already provided useful insights into fundamental biological processes and have been applied in a variety of sectors. Looking forward, further integrating metabolic, regulatory, and replicative functions within synthetic cells will likely yield platforms that are increasingly autonomous and life‑like. This will open up transformative applications across drug delivery, biosensing, regenerative medicine, and environmental remediation, while also posing important challenges in governance, safety, and ethical oversight. As costs continue to decline and technical accessibility improves, the democratization of synthetic cell technology promises to unleash a new era of innovation that could have far‑reaching "halo effects" well beyond the confines of synthetic biology itself <ref name="Sato2022" />, <ref name="Rothschild2024" />.

== References ==
<references />

Synthetic cell demonstrations

2025-09-29T15:26:39Z

Murray: /* Magnetic Activation of Spherical Nucleic Acids for Remote Control of Synthetic Cells (2025) */

This page provides an overview of synthetic cell demonstrations reported in the scientific literature. The information was generated using a prompt requesting examples of synthetic cell demonstrations from specific research groups, processed by Claude Sonnet 4 on August 29, 2025. The examples focus on bottom-up approaches to creating artificial cellular systems with behaviors that can be incorporated into more complex synthetic cell-based systems.

== Vesicle-based demonstrations ==

This section describes selected examples of synthetic cell-based systems where the compartment is a lipid bilayer vesicle.

=== Engineering Genetic Circuit Interactions Within and Between Synthetic Minimal Cells (2017) ===
[[Image:adamala_syncell.png|400px|thumb|alt={Adamala et al., 2017 Figure 1}|
Overview of genetic circuit interactions within and between synthetic cells. Adamala et al, 2017, Figure 1.]]

Adamala and Boyden demonstrated the first robust example of genetic circuit-based communication between populations of synthetic cells. Their system used liposome-encapsulated genetic circuits that they termed "synells" (synthetic minimal cells). The most sophisticated demonstration involved two distinct populations: sensor synells containing IPTG and genetic circuits to produce α-hemolysin, and reporter synells containing circuits that responded to released signaling molecules (doxycycline and IPTG) by expressing firefly luciferase. The α-hemolysin created pores in membranes, allowing controlled release of signaling molecules and establishing cascaded communication between the two cell populations without crosstalk.

Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R., & Boyden, E. S. (2017). [https://doi.org/10.1038/nchem.2644 Engineering genetic circuit interactions within and between synthetic minimal cells]. Nature Chemistry, 9(5), 431-439.
 

=== Cell-Sized Mechanosensitive and Biosensing Compartment Programmed with DNA (2017) ===

[[Image:liu-2017.png|300px|thumb|alt={Booth et al., 2016, Figure 2}|
Mechanosensitive and biosensing synthetic cell system. Majumder et al., 2017, Figure 4.]]

Liu's group at the University of Michigan, in collaboration with Vincent Noireaux at the University of Minnesota, demonstrated synthetic cells capable of coupling mechanical input to biosensing through genetically programmed components. The system used liposomes containing cell-free transcription-translation (TX-TL) reactions that expressed two key proteins: the E. coli mechanosensitive channel of large conductance (MscL) and the calcium biosensor G-GECO. They showed that osmotic pressure changes could activate MscL channels in the synthetic cell membrane, allowing calcium influx that was detected by the co-expressed G-GECO protein through a 23-26 fold increase in fluorescence.

Majumder, S., Garamella, J., Wang, Y. L., DeNies, M., Noireaux, V., & Liu, A. P. (2017). [https://doi.org/10.1039/C7CC03455E Cell-sized mechanosensitive and biosensing compartment programmed with DNA]. Chemical Communications, 53(53), 7349-7352.
 

=== Controlling Secretion in Artificial Cells with a Membrane AND Gate (2019) ===
[[Image:Kamat-2019.jpg|thumb|300px|Schematic of a membrane AND gate. Hilburger et al., 2019, Figure 1.]]

Kamat's group at Northwestern developed artificial cells capable of controlled secretion using a membrane-based AND gate that implements Boolean logic through membrane composition changes. The system used giant unilamellar vesicles containing α-hemolysin protein and required both oleic acid (fatty acid) AND the pore-forming protein to achieve cargo release. The key innovation was controlling when α-hemolysin could functionally assemble into membrane pores based on membrane lipid composition. Initially, vesicles with low oleic acid content prevented α-hemolysin from assembling into functional pores, keeping the membrane impermeable. However, when oleic acid micelles were added externally, they incorporated into the vesicle membrane, changing its composition to enable α-hemolysin assembly into functional heptameric channels. This membrane transformation triggered the release of encapsulated cargo such as calcein. The system demonstrated that membrane-based Boolean logic could complement genetic circuits and provided a new method for temporal control of vesicle permeability through membrane protein-lipid interactions.

Hilburger, C. E., Jacobs, M. L., Lewis, K. R., Peruzzi, J. A., & Kamat, N. P. (2019). [https://doi.org/10.1021/acssynbio.8b00435 Controlling secretion in artificial cells with a membrane AND gate]. ACS Synthetic Biology, 8(6), 1224-1230.
 

=== TXTL-Based Synthetic Cell Systems (2021) ===
[[Image:Noireaux-20121.jpg|thumb|400px|Cell-free expression and synthesis of deGFP in synthetic cells.. Garenne et al., 2021, Figure 4.]]

Noireaux's group developed the all-E. coli TXTL toolbox 3.0 for creating synthetic cell prototypes using cell-free transcription-translation systems. The most sophisticated demonstration involved semi-continuous synthetic cells where liposomes loaded with TXTL reactions could produce enhanced green fluorescent protein (eGFP) at concentrations exceeding 8 mg/ml. This was achieved by allowing chemical building blocks to diffuse through membrane channels, creating a feeding mechanism that sustained protein synthesis over extended periods. The system also demonstrated the synthesis of complex biological entities, including the complete bacteriophage T7 (40 kb genome, ~60 genes) at concentrations of 10^13 PFU/ml.

Garenne, D., Thompson, S., Brisson, A., Khakimzhan, A., & Noireaux, V. (2021). [https://doi.org/10.1093/synbio/ysab017 The all-E. coli TXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform]. Synthetic Biology, 6(1), ysab017.
 

=== Biomimetic Behaviours in Hydrogel Artificial Cells through Embedded Organelles (2023) ===

[[Image:elani-2023.jpg|400px|thumb|alt={Allen et al., 2013, Figure 1}|
Design and function of the hydrogel artificial cells.. Allen et al., 2023 Figure 1.]]

Elani's group at Imperial College developed a microfluidic strategy to create biocompatible cell-sized hydrogel-based artificial cells with embedded functional subcompartments acting as engineered synthetic organelles. They demonstrated artificial cells capable of multiple biomimetic behaviors through modular, interchangeable subcompartments. The system included magnetic particles as "motility organelles" that enabled stimulus-induced movement when exposed to magnetic fields, and lipid vesicle organelles containing encapsulated cargo that could be released in response to specific enzymatic biomarkers. For example, vesicles containing β-galactosidase substrate were embedded within the hydrogel matrix, and when the enzyme was present in the environment, it triggered controlled release of the vesicle contents. The artificial cells also demonstrated enzymatic communication with surrounding bioinspired compartments through cascaded biochemical reactions. This work represents a demonstration of hydrogel-based artificial cells with multiple types of synthetic organelles that could replicate complex cellular behaviors including motility, sensing, content release, and intercellular communication within a single synthetic cell chassis.

Allen, M. E., Hindley, J. W., O'Toole, N., Cooke, H. S., Contini, C., Law, R. V., ... & Elani, Y. (2023). [https://doi.org/10.1073/pnas.2307772120 Biomimetic behaviours in hydrogel artificial cells through embedded organelles]. Proceedings of the National Academy of Sciences, 120(35), e2307772120.
 

=== Self-Organized Spatial Targeting of Contractile Actomyosin Rings for Synthetic Cell Division (2024) ===
[[Image:Schwille-actomyosin-2024.png|thumb|400px|Co-reconstitution of actomyosin networks and the MinDE system enables the reorganization and positioning of actomyosin bundles at mid-cell. Reverte-López et al., 2024, Figure 1.]]

Schwille's group at the Max Planck Institute were able to implement synthetic cell division by successfully combining eukaryotic actomyosin contractile machinery with the bacterial MinDE protein positioning system. The most sophisticated demonstration showed giant unilamellar vesicles containing actomyosin rings that were spatiotemporally positioned at the vesicle equator by MinDE pole-to-pole oscillations through a diffusiophoretic transport mechanism. The MinDE system created active transport of the membrane-bound actomyosin structures via frictional forces, accumulating them at mid-cell in an orientation perpendicular to the oscillation axis. The positioned contractile rings then generated sustained furrow-like membrane invaginations, breaking the spherical symmetry and creating two-lobed vesicles while maintaining the spatial organization. This work represented the first successful integration of spatial positioning machinery with contractile elements to achieve controlled membrane constriction at defined locations, addressing one of the key challenges in synthetic cell division.

Reverte-López, M., Kanwa, N., Qutbuddin, Y., et al. (2024). [https://doi.org/10.1038/s41467-024-54807-9 Self-organized spatial targeting of contractile actomyosin rings for synthetic cell division]. Nature Communications, 15, 10415.
 

=== Magnetic Activation of Spherical Nucleic Acids for Remote Control of Synthetic Cells (2025) ===

[[Image:parkes-2016.png|240px|thumb|alt={Parkes et al., 2025, Figure 5}|
Controlling α-HL expression and cargo release from synthetic cells with an alternating magnetic field.]]
Booth's group at the University of Oxford and University College London developed synthetic cells controlled by clinically tolerable magnetic fields using spherical nucleic acids with magnetic nanoparticle cores. The system used DNA promoter sequences attached to silica-encapsulated iron oxide nanoparticles that could be activated by alternating magnetic fields at 100 kHz—the only clinically approved frequency for magnetic hyperthermia. When exposed to the magnetic field, localized heating from the nanoparticles released T7 promoter sequences that activated cell-free protein synthesis within giant unilamellar vesicles. The most sophisticated demonstrations showed magnetically controlled expression of mNeonGreen fluorescent protein and α-hemolysin pore-forming protein, which enabled on-demand cargo release from synthetic cells. The system maintained tight control with minimal background activity in the absence of magnetic fields through a novel purification method that removed electrostatically bound DNA. Critically, the technology operated through opaque blocking materials that are impenetrable to current activation methods like light or small molecules, demonstrating the potential of deeply tissue-penetrating magnetic fields for controlling synthetic cells as drug delivery devices.

Parkes, E., Al Samad, A., Mazzotti, G., Newell, C., Ng, B., Radford, A., & Booth, M. J. (2025). [https://doi.org/10.1038/s41557-025-01909-6 Magnetic activation of spherical nucleic acids enables the remote control of synthetic cells]. Nature Chemistry (published online).
 

== Other compartmentalization techniques ==

This section describes selected examples of systems where the compartment is something other than a lipid bilayer-based vesicle.

=== Light-Activated Communication in Synthetic Tissues (2016) ===

[[Image:booth-2016.jpg|400px|thumb|alt={Booth et al., 2016, Figure 2}|
Light-activated expression of LA-mVenus in synthetic cells and synthetic tissues. Booth et al., 2016 Figure 2.]]

Booth and colleagues developed one of the earliest demonstrations of communication between droplet-based synthetic cells using light-activated control systems. The system involved 3D-printing droplets containing PURE cell-free transcription-translation (TX-TL) systems that could produce α-hemolysin pore proteins upon light activation. When these pore proteins were incorporated into specific bilayer interfaces, they mediated rapid, directional electrical communication between subsets of artificial cells, mimicking neural transmission in living tissue. The light activation provided precise spatial and temporal control over which cells could communicate, creating the first demonstration of tissue-like organization in synthetic cell systems.

Booth, M. J., Schild, V. R., Graham, A. D., Olof, S. N., & Bayley, H. (2016). [https://doi.org/10.1126/sciadv.1600056 Light-activated communication in synthetic tissues]. Science Advances, 2(4), e1600056.
 

=== Communication and Quorum Sensing in Artificial Cells (2018) ===
[[Image:Niederholtmeyer-2018.png|thumb|300px|Communication between cell-mimics via a diffusive genetic activator. Niederholtmeyer et al., 2018, Figure 3.]]

Devaraj’s group at UC San Diego developed artificial cells capable of chemical communication using quorum-sensing genetic circuits encapsulated inside a porous polymer membrane containing an artificial hydrogel compartment. "Activator" synthetic cells produced T3 RNAP, which diffused through the polymer membrane into "detector" synthetic cells that expressed GFP. The system demonstrated that non-living vesicle-based mimics could exchange information through diffusible signaling molecules, allowing one population of artificial cells to regulate gene expression in another. This work provided a demonstrations of intercellular communication between synthetic cells and highlighted the potential of quorum sensing as a design principle for coordinating behavior in cell-free systems.

Niederholtmeyer, H., Chaggan, C., & Devaraj, N. K. (2018). [https://doi.org/10.1038/s41467-018-07473-7 Communication and quorum sensing in non-living mimics of eukaryotic cells]. Nature Communications, 9, 5027.
 

=== DNA-Based Communication in Populations of Synthetic Protocells (2019) ===
[[File:Joesaar-2019.png|thumb|400px|PCompartmentalized DNA-based Boolean logic circuits. Joesaar et al, 2019, Figure 5.]]

Joesaar, Mann, de Greef and colleagues developed a highly sophisticated platform called "biomolecular implementation of protocellular communication" (BIO-PC) using proteinosomes as artificial cell chassis. The system leveraged enzyme-free DNA strand-displacement circuits encapsulated within semipermeable protein-polymer microcapsules. The most complex demonstration showed bidirectional communication and distributed computational operations, where protocells could sense DNA-based input messages, process them through programmable logic circuits, and secrete output DNA strands that activated neighboring protocells. The encapsulation protected the DNA circuits from nuclease degradation, allowing operation in concentrated serum conditions.

Joesaar, A., Yang, S., Bögels, B., van der Linden, A., Pieters, P., Kumar, B. V. V. S. P., ... & de Greef, T. F. A. (2019). [https://doi.org/10.1038/s41565-019-0399-9 DNA-based communication in populations of synthetic protocells]. Nature Nanotechnology, 14(4), 369-378.

File:Parkes-2016.png

2025-09-29T15:25:41Z

Murray:

Synthetic cell demonstrations

2025-09-29T15:25:03Z

Murray: /* Magnetic Activation of Spherical Nucleic Acids for Remote Control of Synthetic Cells (2025) */

This page provides an overview of synthetic cell demonstrations reported in the scientific literature. The information was generated using a prompt requesting examples of synthetic cell demonstrations from specific research groups, processed by Claude Sonnet 4 on August 29, 2025. The examples focus on bottom-up approaches to creating artificial cellular systems with behaviors that can be incorporated into more complex synthetic cell-based systems.

== Vesicle-based demonstrations ==

This section describes selected examples of synthetic cell-based systems where the compartment is a lipid bilayer vesicle.

=== Engineering Genetic Circuit Interactions Within and Between Synthetic Minimal Cells (2017) ===
[[Image:adamala_syncell.png|400px|thumb|alt={Adamala et al., 2017 Figure 1}|
Overview of genetic circuit interactions within and between synthetic cells. Adamala et al, 2017, Figure 1.]]

Adamala and Boyden demonstrated the first robust example of genetic circuit-based communication between populations of synthetic cells. Their system used liposome-encapsulated genetic circuits that they termed "synells" (synthetic minimal cells). The most sophisticated demonstration involved two distinct populations: sensor synells containing IPTG and genetic circuits to produce α-hemolysin, and reporter synells containing circuits that responded to released signaling molecules (doxycycline and IPTG) by expressing firefly luciferase. The α-hemolysin created pores in membranes, allowing controlled release of signaling molecules and establishing cascaded communication between the two cell populations without crosstalk.

Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R., & Boyden, E. S. (2017). [https://doi.org/10.1038/nchem.2644 Engineering genetic circuit interactions within and between synthetic minimal cells]. Nature Chemistry, 9(5), 431-439.
 

=== Cell-Sized Mechanosensitive and Biosensing Compartment Programmed with DNA (2017) ===

[[Image:liu-2017.png|300px|thumb|alt={Booth et al., 2016, Figure 2}|
Mechanosensitive and biosensing synthetic cell system. Majumder et al., 2017, Figure 4.]]

Liu's group at the University of Michigan, in collaboration with Vincent Noireaux at the University of Minnesota, demonstrated synthetic cells capable of coupling mechanical input to biosensing through genetically programmed components. The system used liposomes containing cell-free transcription-translation (TX-TL) reactions that expressed two key proteins: the E. coli mechanosensitive channel of large conductance (MscL) and the calcium biosensor G-GECO. They showed that osmotic pressure changes could activate MscL channels in the synthetic cell membrane, allowing calcium influx that was detected by the co-expressed G-GECO protein through a 23-26 fold increase in fluorescence.

Majumder, S., Garamella, J., Wang, Y. L., DeNies, M., Noireaux, V., & Liu, A. P. (2017). [https://doi.org/10.1039/C7CC03455E Cell-sized mechanosensitive and biosensing compartment programmed with DNA]. Chemical Communications, 53(53), 7349-7352.
 

=== Controlling Secretion in Artificial Cells with a Membrane AND Gate (2019) ===
[[Image:Kamat-2019.jpg|thumb|300px|Schematic of a membrane AND gate. Hilburger et al., 2019, Figure 1.]]

Kamat's group at Northwestern developed artificial cells capable of controlled secretion using a membrane-based AND gate that implements Boolean logic through membrane composition changes. The system used giant unilamellar vesicles containing α-hemolysin protein and required both oleic acid (fatty acid) AND the pore-forming protein to achieve cargo release. The key innovation was controlling when α-hemolysin could functionally assemble into membrane pores based on membrane lipid composition. Initially, vesicles with low oleic acid content prevented α-hemolysin from assembling into functional pores, keeping the membrane impermeable. However, when oleic acid micelles were added externally, they incorporated into the vesicle membrane, changing its composition to enable α-hemolysin assembly into functional heptameric channels. This membrane transformation triggered the release of encapsulated cargo such as calcein. The system demonstrated that membrane-based Boolean logic could complement genetic circuits and provided a new method for temporal control of vesicle permeability through membrane protein-lipid interactions.

Hilburger, C. E., Jacobs, M. L., Lewis, K. R., Peruzzi, J. A., & Kamat, N. P. (2019). [https://doi.org/10.1021/acssynbio.8b00435 Controlling secretion in artificial cells with a membrane AND gate]. ACS Synthetic Biology, 8(6), 1224-1230.
 

=== TXTL-Based Synthetic Cell Systems (2021) ===
[[Image:Noireaux-20121.jpg|thumb|400px|Cell-free expression and synthesis of deGFP in synthetic cells.. Garenne et al., 2021, Figure 4.]]

Noireaux's group developed the all-E. coli TXTL toolbox 3.0 for creating synthetic cell prototypes using cell-free transcription-translation systems. The most sophisticated demonstration involved semi-continuous synthetic cells where liposomes loaded with TXTL reactions could produce enhanced green fluorescent protein (eGFP) at concentrations exceeding 8 mg/ml. This was achieved by allowing chemical building blocks to diffuse through membrane channels, creating a feeding mechanism that sustained protein synthesis over extended periods. The system also demonstrated the synthesis of complex biological entities, including the complete bacteriophage T7 (40 kb genome, ~60 genes) at concentrations of 10^13 PFU/ml.

Garenne, D., Thompson, S., Brisson, A., Khakimzhan, A., & Noireaux, V. (2021). [https://doi.org/10.1093/synbio/ysab017 The all-E. coli TXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform]. Synthetic Biology, 6(1), ysab017.
 

=== Biomimetic Behaviours in Hydrogel Artificial Cells through Embedded Organelles (2023) ===

[[Image:elani-2023.jpg|400px|thumb|alt={Allen et al., 2013, Figure 1}|
Design and function of the hydrogel artificial cells.. Allen et al., 2023 Figure 1.]]

Elani's group at Imperial College developed a microfluidic strategy to create biocompatible cell-sized hydrogel-based artificial cells with embedded functional subcompartments acting as engineered synthetic organelles. They demonstrated artificial cells capable of multiple biomimetic behaviors through modular, interchangeable subcompartments. The system included magnetic particles as "motility organelles" that enabled stimulus-induced movement when exposed to magnetic fields, and lipid vesicle organelles containing encapsulated cargo that could be released in response to specific enzymatic biomarkers. For example, vesicles containing β-galactosidase substrate were embedded within the hydrogel matrix, and when the enzyme was present in the environment, it triggered controlled release of the vesicle contents. The artificial cells also demonstrated enzymatic communication with surrounding bioinspired compartments through cascaded biochemical reactions. This work represents a demonstration of hydrogel-based artificial cells with multiple types of synthetic organelles that could replicate complex cellular behaviors including motility, sensing, content release, and intercellular communication within a single synthetic cell chassis.

Allen, M. E., Hindley, J. W., O'Toole, N., Cooke, H. S., Contini, C., Law, R. V., ... & Elani, Y. (2023). [https://doi.org/10.1073/pnas.2307772120 Biomimetic behaviours in hydrogel artificial cells through embedded organelles]. Proceedings of the National Academy of Sciences, 120(35), e2307772120.
 

=== Self-Organized Spatial Targeting of Contractile Actomyosin Rings for Synthetic Cell Division (2024) ===
[[Image:Schwille-actomyosin-2024.png|thumb|400px|Co-reconstitution of actomyosin networks and the MinDE system enables the reorganization and positioning of actomyosin bundles at mid-cell. Reverte-López et al., 2024, Figure 1.]]

Schwille's group at the Max Planck Institute were able to implement synthetic cell division by successfully combining eukaryotic actomyosin contractile machinery with the bacterial MinDE protein positioning system. The most sophisticated demonstration showed giant unilamellar vesicles containing actomyosin rings that were spatiotemporally positioned at the vesicle equator by MinDE pole-to-pole oscillations through a diffusiophoretic transport mechanism. The MinDE system created active transport of the membrane-bound actomyosin structures via frictional forces, accumulating them at mid-cell in an orientation perpendicular to the oscillation axis. The positioned contractile rings then generated sustained furrow-like membrane invaginations, breaking the spherical symmetry and creating two-lobed vesicles while maintaining the spatial organization. This work represented the first successful integration of spatial positioning machinery with contractile elements to achieve controlled membrane constriction at defined locations, addressing one of the key challenges in synthetic cell division.

Reverte-López, M., Kanwa, N., Qutbuddin, Y., et al. (2024). [https://doi.org/10.1038/s41467-024-54807-9 Self-organized spatial targeting of contractile actomyosin rings for synthetic cell division]. Nature Communications, 15, 10415.
 

=== Magnetic Activation of Spherical Nucleic Acids for Remote Control of Synthetic Cells (2025) ===

[[Image:parkes-2016.png|300px|thumb|alt={Parkes et al., 2025, Figure 5}|
Controlling α-HL expression and cargo release from synthetic cells with an alternating magnetic field.]]
Booth's group at the University of Oxford and University College London developed synthetic cells controlled by clinically tolerable magnetic fields using spherical nucleic acids with magnetic nanoparticle cores. The system used DNA promoter sequences attached to silica-encapsulated iron oxide nanoparticles that could be activated by alternating magnetic fields at 100 kHz—the only clinically approved frequency for magnetic hyperthermia. When exposed to the magnetic field, localized heating from the nanoparticles released T7 promoter sequences that activated cell-free protein synthesis within giant unilamellar vesicles. The most sophisticated demonstrations showed magnetically controlled expression of mNeonGreen fluorescent protein and α-hemolysin pore-forming protein, which enabled on-demand cargo release from synthetic cells. The system maintained tight control with minimal background activity in the absence of magnetic fields through a novel purification method that removed electrostatically bound DNA. Critically, the technology operated through opaque blocking materials that are impenetrable to current activation methods like light or small molecules, demonstrating the potential of deeply tissue-penetrating magnetic fields for controlling synthetic cells as drug delivery devices.

Parkes, E., Al Samad, A., Mazzotti, G., Newell, C., Ng, B., Radford, A., & Booth, M. J. (2025). [https://doi.org/10.1038/s41557-025-01909-6 Magnetic activation of spherical nucleic acids enables the remote control of synthetic cells]. Nature Chemistry (published online).
 

== Other compartmentalization techniques ==

This section describes selected examples of systems where the compartment is something other than a lipid bilayer-based vesicle.

=== Light-Activated Communication in Synthetic Tissues (2016) ===

[[Image:booth-2016.jpg|400px|thumb|alt={Booth et al., 2016, Figure 2}|
Light-activated expression of LA-mVenus in synthetic cells and synthetic tissues. Booth et al., 2016 Figure 2.]]

Booth and colleagues developed one of the earliest demonstrations of communication between droplet-based synthetic cells using light-activated control systems. The system involved 3D-printing droplets containing PURE cell-free transcription-translation (TX-TL) systems that could produce α-hemolysin pore proteins upon light activation. When these pore proteins were incorporated into specific bilayer interfaces, they mediated rapid, directional electrical communication between subsets of artificial cells, mimicking neural transmission in living tissue. The light activation provided precise spatial and temporal control over which cells could communicate, creating the first demonstration of tissue-like organization in synthetic cell systems.

Booth, M. J., Schild, V. R., Graham, A. D., Olof, S. N., & Bayley, H. (2016). [https://doi.org/10.1126/sciadv.1600056 Light-activated communication in synthetic tissues]. Science Advances, 2(4), e1600056.
 

=== Communication and Quorum Sensing in Artificial Cells (2018) ===
[[Image:Niederholtmeyer-2018.png|thumb|300px|Communication between cell-mimics via a diffusive genetic activator. Niederholtmeyer et al., 2018, Figure 3.]]

Devaraj’s group at UC San Diego developed artificial cells capable of chemical communication using quorum-sensing genetic circuits encapsulated inside a porous polymer membrane containing an artificial hydrogel compartment. "Activator" synthetic cells produced T3 RNAP, which diffused through the polymer membrane into "detector" synthetic cells that expressed GFP. The system demonstrated that non-living vesicle-based mimics could exchange information through diffusible signaling molecules, allowing one population of artificial cells to regulate gene expression in another. This work provided a demonstrations of intercellular communication between synthetic cells and highlighted the potential of quorum sensing as a design principle for coordinating behavior in cell-free systems.

Niederholtmeyer, H., Chaggan, C., & Devaraj, N. K. (2018). [https://doi.org/10.1038/s41467-018-07473-7 Communication and quorum sensing in non-living mimics of eukaryotic cells]. Nature Communications, 9, 5027.
 

=== DNA-Based Communication in Populations of Synthetic Protocells (2019) ===
[[File:Joesaar-2019.png|thumb|400px|PCompartmentalized DNA-based Boolean logic circuits. Joesaar et al, 2019, Figure 5.]]

Joesaar, Mann, de Greef and colleagues developed a highly sophisticated platform called "biomolecular implementation of protocellular communication" (BIO-PC) using proteinosomes as artificial cell chassis. The system leveraged enzyme-free DNA strand-displacement circuits encapsulated within semipermeable protein-polymer microcapsules. The most complex demonstration showed bidirectional communication and distributed computational operations, where protocells could sense DNA-based input messages, process them through programmable logic circuits, and secrete output DNA strands that activated neighboring protocells. The encapsulation protected the DNA circuits from nuclease degradation, allowing operation in concentrated serum conditions.

Joesaar, A., Yang, S., Bögels, B., van der Linden, A., Pieters, P., Kumar, B. V. V. S. P., ... & de Greef, T. F. A. (2019). [https://doi.org/10.1038/s41565-019-0399-9 DNA-based communication in populations of synthetic protocells]. Nature Nanotechnology, 14(4), 369-378.

Synthetic cell demonstrations

2025-09-29T15:23:48Z

Murray:

This page provides an overview of synthetic cell demonstrations reported in the scientific literature. The information was generated using a prompt requesting examples of synthetic cell demonstrations from specific research groups, processed by Claude Sonnet 4 on August 29, 2025. The examples focus on bottom-up approaches to creating artificial cellular systems with behaviors that can be incorporated into more complex synthetic cell-based systems.

== Vesicle-based demonstrations ==

This section describes selected examples of synthetic cell-based systems where the compartment is a lipid bilayer vesicle.

=== Engineering Genetic Circuit Interactions Within and Between Synthetic Minimal Cells (2017) ===
[[Image:adamala_syncell.png|400px|thumb|alt={Adamala et al., 2017 Figure 1}|
Overview of genetic circuit interactions within and between synthetic cells. Adamala et al, 2017, Figure 1.]]

Adamala and Boyden demonstrated the first robust example of genetic circuit-based communication between populations of synthetic cells. Their system used liposome-encapsulated genetic circuits that they termed "synells" (synthetic minimal cells). The most sophisticated demonstration involved two distinct populations: sensor synells containing IPTG and genetic circuits to produce α-hemolysin, and reporter synells containing circuits that responded to released signaling molecules (doxycycline and IPTG) by expressing firefly luciferase. The α-hemolysin created pores in membranes, allowing controlled release of signaling molecules and establishing cascaded communication between the two cell populations without crosstalk.

Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R., & Boyden, E. S. (2017). [https://doi.org/10.1038/nchem.2644 Engineering genetic circuit interactions within and between synthetic minimal cells]. Nature Chemistry, 9(5), 431-439.
 

=== Cell-Sized Mechanosensitive and Biosensing Compartment Programmed with DNA (2017) ===

[[Image:liu-2017.png|300px|thumb|alt={Booth et al., 2016, Figure 2}|
Mechanosensitive and biosensing synthetic cell system. Majumder et al., 2017, Figure 4.]]

Liu's group at the University of Michigan, in collaboration with Vincent Noireaux at the University of Minnesota, demonstrated synthetic cells capable of coupling mechanical input to biosensing through genetically programmed components. The system used liposomes containing cell-free transcription-translation (TX-TL) reactions that expressed two key proteins: the E. coli mechanosensitive channel of large conductance (MscL) and the calcium biosensor G-GECO. They showed that osmotic pressure changes could activate MscL channels in the synthetic cell membrane, allowing calcium influx that was detected by the co-expressed G-GECO protein through a 23-26 fold increase in fluorescence.

Majumder, S., Garamella, J., Wang, Y. L., DeNies, M., Noireaux, V., & Liu, A. P. (2017). [https://doi.org/10.1039/C7CC03455E Cell-sized mechanosensitive and biosensing compartment programmed with DNA]. Chemical Communications, 53(53), 7349-7352.
 

=== Controlling Secretion in Artificial Cells with a Membrane AND Gate (2019) ===
[[Image:Kamat-2019.jpg|thumb|300px|Schematic of a membrane AND gate. Hilburger et al., 2019, Figure 1.]]

Kamat's group at Northwestern developed artificial cells capable of controlled secretion using a membrane-based AND gate that implements Boolean logic through membrane composition changes. The system used giant unilamellar vesicles containing α-hemolysin protein and required both oleic acid (fatty acid) AND the pore-forming protein to achieve cargo release. The key innovation was controlling when α-hemolysin could functionally assemble into membrane pores based on membrane lipid composition. Initially, vesicles with low oleic acid content prevented α-hemolysin from assembling into functional pores, keeping the membrane impermeable. However, when oleic acid micelles were added externally, they incorporated into the vesicle membrane, changing its composition to enable α-hemolysin assembly into functional heptameric channels. This membrane transformation triggered the release of encapsulated cargo such as calcein. The system demonstrated that membrane-based Boolean logic could complement genetic circuits and provided a new method for temporal control of vesicle permeability through membrane protein-lipid interactions.

Hilburger, C. E., Jacobs, M. L., Lewis, K. R., Peruzzi, J. A., & Kamat, N. P. (2019). [https://doi.org/10.1021/acssynbio.8b00435 Controlling secretion in artificial cells with a membrane AND gate]. ACS Synthetic Biology, 8(6), 1224-1230.
 

=== TXTL-Based Synthetic Cell Systems (2021) ===
[[Image:Noireaux-20121.jpg|thumb|400px|Cell-free expression and synthesis of deGFP in synthetic cells.. Garenne et al., 2021, Figure 4.]]

Noireaux's group developed the all-E. coli TXTL toolbox 3.0 for creating synthetic cell prototypes using cell-free transcription-translation systems. The most sophisticated demonstration involved semi-continuous synthetic cells where liposomes loaded with TXTL reactions could produce enhanced green fluorescent protein (eGFP) at concentrations exceeding 8 mg/ml. This was achieved by allowing chemical building blocks to diffuse through membrane channels, creating a feeding mechanism that sustained protein synthesis over extended periods. The system also demonstrated the synthesis of complex biological entities, including the complete bacteriophage T7 (40 kb genome, ~60 genes) at concentrations of 10^13 PFU/ml.

Garenne, D., Thompson, S., Brisson, A., Khakimzhan, A., & Noireaux, V. (2021). [https://doi.org/10.1093/synbio/ysab017 The all-E. coli TXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform]. Synthetic Biology, 6(1), ysab017.
 

=== Biomimetic Behaviours in Hydrogel Artificial Cells through Embedded Organelles (2023) ===

[[Image:elani-2023.jpg|400px|thumb|alt={Allen et al., 2013, Figure 1}|
Design and function of the hydrogel artificial cells.. Allen et al., 2023 Figure 1.]]

Elani's group at Imperial College developed a microfluidic strategy to create biocompatible cell-sized hydrogel-based artificial cells with embedded functional subcompartments acting as engineered synthetic organelles. They demonstrated artificial cells capable of multiple biomimetic behaviors through modular, interchangeable subcompartments. The system included magnetic particles as "motility organelles" that enabled stimulus-induced movement when exposed to magnetic fields, and lipid vesicle organelles containing encapsulated cargo that could be released in response to specific enzymatic biomarkers. For example, vesicles containing β-galactosidase substrate were embedded within the hydrogel matrix, and when the enzyme was present in the environment, it triggered controlled release of the vesicle contents. The artificial cells also demonstrated enzymatic communication with surrounding bioinspired compartments through cascaded biochemical reactions. This work represents a demonstration of hydrogel-based artificial cells with multiple types of synthetic organelles that could replicate complex cellular behaviors including motility, sensing, content release, and intercellular communication within a single synthetic cell chassis.

Allen, M. E., Hindley, J. W., O'Toole, N., Cooke, H. S., Contini, C., Law, R. V., ... & Elani, Y. (2023). [https://doi.org/10.1073/pnas.2307772120 Biomimetic behaviours in hydrogel artificial cells through embedded organelles]. Proceedings of the National Academy of Sciences, 120(35), e2307772120.
 

=== Self-Organized Spatial Targeting of Contractile Actomyosin Rings for Synthetic Cell Division (2024) ===
[[Image:Schwille-actomyosin-2024.png|thumb|400px|Co-reconstitution of actomyosin networks and the MinDE system enables the reorganization and positioning of actomyosin bundles at mid-cell. Reverte-López et al., 2024, Figure 1.]]

Schwille's group at the Max Planck Institute were able to implement synthetic cell division by successfully combining eukaryotic actomyosin contractile machinery with the bacterial MinDE protein positioning system. The most sophisticated demonstration showed giant unilamellar vesicles containing actomyosin rings that were spatiotemporally positioned at the vesicle equator by MinDE pole-to-pole oscillations through a diffusiophoretic transport mechanism. The MinDE system created active transport of the membrane-bound actomyosin structures via frictional forces, accumulating them at mid-cell in an orientation perpendicular to the oscillation axis. The positioned contractile rings then generated sustained furrow-like membrane invaginations, breaking the spherical symmetry and creating two-lobed vesicles while maintaining the spatial organization. This work represented the first successful integration of spatial positioning machinery with contractile elements to achieve controlled membrane constriction at defined locations, addressing one of the key challenges in synthetic cell division.

Reverte-López, M., Kanwa, N., Qutbuddin, Y., et al. (2024). [https://doi.org/10.1038/s41467-024-54807-9 Self-organized spatial targeting of contractile actomyosin rings for synthetic cell division]. Nature Communications, 15, 10415.
 

=== Magnetic Activation of Spherical Nucleic Acids for Remote Control of Synthetic Cells (2025) ===

[[Image:parkes-2016.png|300px|thumb|alt={Parkes et al., 2025, Figure 5}|
Booth's group at the University of Oxford and University College London developed synthetic cells controlled by clinically tolerable magnetic fields using spherical nucleic acids with magnetic nanoparticle cores. The system used DNA promoter sequences attached to silica-encapsulated iron oxide nanoparticles that could be activated by alternating magnetic fields at 100 kHz—the only clinically approved frequency for magnetic hyperthermia. When exposed to the magnetic field, localized heating from the nanoparticles released T7 promoter sequences that activated cell-free protein synthesis within giant unilamellar vesicles. The most sophisticated demonstrations showed magnetically controlled expression of mNeonGreen fluorescent protein and α-hemolysin pore-forming protein, which enabled on-demand cargo release from synthetic cells. The system maintained tight control with minimal background activity in the absence of magnetic fields through a novel purification method that removed electrostatically bound DNA. Critically, the technology operated through opaque blocking materials that are impenetrable to current activation methods like light or small molecules, demonstrating the potential of deeply tissue-penetrating magnetic fields for controlling synthetic cells as drug delivery devices.

Parkes, E., Al Samad, A., Mazzotti, G., Newell, C., Ng, B., Radford, A., & Booth, M. J. (2025). [https://doi.org/10.1038/s41557-025-01909-6 Magnetic activation of spherical nucleic acids enables the remote control of synthetic cells]. Nature Chemistry (published online).
 

== Other compartmentalization techniques ==

This section describes selected examples of systems where the compartment is something other than a lipid bilayer-based vesicle.

=== Light-Activated Communication in Synthetic Tissues (2016) ===

[[Image:booth-2016.jpg|400px|thumb|alt={Booth et al., 2016, Figure 2}|
Light-activated expression of LA-mVenus in synthetic cells and synthetic tissues. Booth et al., 2016 Figure 2.]]

Booth and colleagues developed one of the earliest demonstrations of communication between droplet-based synthetic cells using light-activated control systems. The system involved 3D-printing droplets containing PURE cell-free transcription-translation (TX-TL) systems that could produce α-hemolysin pore proteins upon light activation. When these pore proteins were incorporated into specific bilayer interfaces, they mediated rapid, directional electrical communication between subsets of artificial cells, mimicking neural transmission in living tissue. The light activation provided precise spatial and temporal control over which cells could communicate, creating the first demonstration of tissue-like organization in synthetic cell systems.

Booth, M. J., Schild, V. R., Graham, A. D., Olof, S. N., & Bayley, H. (2016). [https://doi.org/10.1126/sciadv.1600056 Light-activated communication in synthetic tissues]. Science Advances, 2(4), e1600056.
 

=== Communication and Quorum Sensing in Artificial Cells (2018) ===
[[Image:Niederholtmeyer-2018.png|thumb|300px|Communication between cell-mimics via a diffusive genetic activator. Niederholtmeyer et al., 2018, Figure 3.]]

Devaraj’s group at UC San Diego developed artificial cells capable of chemical communication using quorum-sensing genetic circuits encapsulated inside a porous polymer membrane containing an artificial hydrogel compartment. "Activator" synthetic cells produced T3 RNAP, which diffused through the polymer membrane into "detector" synthetic cells that expressed GFP. The system demonstrated that non-living vesicle-based mimics could exchange information through diffusible signaling molecules, allowing one population of artificial cells to regulate gene expression in another. This work provided a demonstrations of intercellular communication between synthetic cells and highlighted the potential of quorum sensing as a design principle for coordinating behavior in cell-free systems.

Niederholtmeyer, H., Chaggan, C., & Devaraj, N. K. (2018). [https://doi.org/10.1038/s41467-018-07473-7 Communication and quorum sensing in non-living mimics of eukaryotic cells]. Nature Communications, 9, 5027.
 

=== DNA-Based Communication in Populations of Synthetic Protocells (2019) ===
[[File:Joesaar-2019.png|thumb|400px|PCompartmentalized DNA-based Boolean logic circuits. Joesaar et al, 2019, Figure 5.]]

Joesaar, Mann, de Greef and colleagues developed a highly sophisticated platform called "biomolecular implementation of protocellular communication" (BIO-PC) using proteinosomes as artificial cell chassis. The system leveraged enzyme-free DNA strand-displacement circuits encapsulated within semipermeable protein-polymer microcapsules. The most complex demonstration showed bidirectional communication and distributed computational operations, where protocells could sense DNA-based input messages, process them through programmable logic circuits, and secrete output DNA strands that activated neighboring protocells. The encapsulation protected the DNA circuits from nuclease degradation, allowing operation in concentrated serum conditions.

Joesaar, A., Yang, S., Bögels, B., van der Linden, A., Pieters, P., Kumar, B. V. V. S. P., ... & de Greef, T. F. A. (2019). [https://doi.org/10.1038/s41565-019-0399-9 DNA-based communication in populations of synthetic protocells]. Nature Nanotechnology, 14(4), 369-378.

Main Page

2025-09-13T04:51:01Z

Murray: /* Modeling and Specifications */

Welcome to the Synthetic Cell Wiki (SynCellWiki). This wiki contains information about synthetic cells and is intended as a reference manual for engineers who are interested in using synthetic cells to engineer biology.

== What is a Synthetic Cell? ==
[[Image:synthetic-cell-overview.jpg|right|400px|thumb|alt={Synthetic cell platforms}|
Four different molecular platforms for studying synthetic cells. ''ACS Synthetic Biology'', 13(4):974-997, 2024<ref name="Ros+2024:ACSsynbio"/>. CC BY-NC-ND.]]

The term "synthetic cell" is not well-defined and different groups have used it in different ways over time. Other terms are also used: artificial cells, developer cells, and protocells are some examples. What all of these definitions have in common is the notion of some sort of contained and engineered biomolecular machine that carries out functions similar to that of a living cell. Some of the major categories of synthetic cells include:

* '''Encapsulated cell-free systems''': A system consisting of a container of some sort, with biomolecular machinery inside the contained region that carries out biomolecular functions (transcription, translation, sensing, chemical processing, motility, etc). Synthetic cells in this class can range from very simple artificial vesicles containing a few proteins to complex biomolecular machines that carry out complex functions. As a general rule, synthetic cells in this category are not self-replicating, though they may include mechanisms for assembly into more complex consortia or multi-cellular machines.

* '''Biomimetic synthetic cells''': A system that carries the key functions of a living cell, typically including compartmentalization, replication, and metabolism. These systems do not yet exist, but significant progress has been made on each of the basic functions, often using encapusulated cell-free systems as a starting point. A recent review and roadmap for this class of systems has been written by members of the US Build-A-Cell<ref>https://buildacell.org. Retrieved 19 Jul 2025.</ref> consortium (Rosthschild et al, 2024<ref name="Ros+2024:ACSsynbio">L. J. Rothschild, N. J. H. Averesch, E. A. Strychalski, F. Moser, J. I. Glass, R. Cruz Perez, I. O. Yekinni, B. Rothschild-Mancinelli, G. A. Roberts Kingman, F. Wu, J. Waeterschoot, I. A. Ioannou, M. C. Jewett, A. P. Liu, V. Noireaux, C. Sorenson, and K. P. Adamala, [https://pubs.acs.org/doi/10.1021/acssynbio.3c00724 Building synthetic cells─From the technology infrastructure to cellular entities]. ''ACS Synthetic Biology'' 13(4):974-997, 2024. DOI: 10.1021/acssynbio.3c00724</ref>).

* '''Minimal cells''': A natural cell that has been heavily modified to utilize a minimized chromosome while still supporting life. The prototypical minimal cell is JCVI-syn3.0<ref>C. A. Hutchison III, R.-Y. Chuang, V. N. Noskov, N. Assad-Garcia, T. J. Deerinck, M. H. Ellisman, J. Gill, K. Kannan, B. J. Karas, L. Ma, J. F. Pelletier, Z.-Q. Qi, R. A. Richter, E. A. Strychalski, L. Sun, Y. Suzuki, B. Tsvetanova, K. S. Wise, H. O. Smith, J. I. Glass, C. Merryman, D. G. Gibson, and J. C. Venter, [https://www.science.org/doi/10.1126/science.aad6253 Design and synthesis of a minimal bacterial genome]. Science 351:aad6253, 2016. DOI:10.1126/science.aad6253</ref>, which consists of a modified ''Mycoplasma mycoides'' bacteria that has been modified to contain only 531,000 base pairs encoding 473 genes, making it the smallest genome of any self-replicating organism.

In this wiki, we will primarily focus on the technologies involved in the first two classes of synthetic cells, which are often referred to as "bottoms-up" synthetic cells, since they are built from non-living components.

== How Could Synthetic Cells Be Useful? ==

This section summarizes some of the potential applications for synthetic cells. The [[Synthetic Cell Applications]] page has a more detailed analysis of current and future applications of synthetic cells.

=== Long Term Vision: Building Biological Machines at Scale ===

[[Image:syncell-ant.png|right|240px|thumb|alt={Synthetic ants}|Carpenter ant, showing some of the different subsystems. CC BY-SA, [https://commons.wikimedia.org/wiki/File:Muurahainen.svg Jpant via Wikimedia Commons], 2006]]
A long term goal for synthetic cells is to enable predictable engineering of complex "biomachines", where a biomachine is an engineered system that makes use of biomolecules to carry out a useful function. For example, imagine a world in which engineers can design and build a device that is 1-2 mm long, operates for 24 hours, and can be programmed to explore small spaces and retrieve objects and substances with well-defined chemical, mechanical, or optical properties. In nature, this is called a carpenter ant, and it consists of ~20M cells that allow the ant to explore its environment, find food or building materials for its nest, and communicate with other ants. The various cells in the ant carry out different functions (muscles, energy conversion, sensing, decision making, etc.) and are assembled together in a fashion that allows the system to operate autonomously, much like a self-driving car is able navigate on city streets. While engineers are able to build self-driving cars, we have not yet developed and mastered the engineering processes and workflows needed to engineer a system at the millimeter scale that can carry out similarly useful functions.

[[Image:syncell-plant.png|left|240px|thumb|alt={Synthetic plants}|Conceptual synthetic plant, growing multiple fruits. Original figure courtesy LSU Ag Center, 2021]]
As a second example, imagine a biological machine that can extract chemicals and energy from the environment around it, transport the chemicals to processing centers where it combines and converts them into new molecules, and then transports them to packaging centers where its assembles them into a useful form. In nature, this is called an orange tree. The chemical engineering discipline can build machines that have these same high level functions (perhaps to produce chocolate oranges<ref>https://en.wikipedia.org/wiki/Terry%27s_Chocolate_Orange. Retrieved 19 Jul 2025.</ref> [invented in 1932!]), but we don't know how to build a biological machine at this level of complexity and function. If we could, we might even be able to engineer it so that it made different types of fruits on different branche (apples, oranges, and plums?), or build different variants of the machine that were tuned to operate in different types of climate (from rainforests to semi-arid plains, depending on the model that you choose).

[[Image:syncell-slime.png|right|240px|thumb|alt={Synthetic slimes (biofilms)}|Depiction of a biofilm. ARL CCDC, 2019.]]As a final example, and perhaps the most achievable in the near term, consider the idea of embedding synthetic cells into artificial and/or hybrid materials, similar to biofilms or perhaps slime molds. In this instantiation of synthetic, multicellular biomachines, the individual synthetic cells embedded in a material could sense conditions in their local environment and change the properties of the material in response to those conditions. For example, a material might adjust its mechanical or optical properties based on changes in temperature or chemical cues. Synthetic cells embedded in materials could also export chemicals to interact with the environment, perhaps degrading toxins or killing harmful organisms on the surface.

For all three of these cases (ants, plants, and slimes), synthetic cells are a possible starting point for many of the nanoscale and microscale functions that would need to be combined to produce these (multicellular) complex biomachines. Of course, there is no reason that these would need to mimic their natural counterparts completely. For example, rather than figuring out how to have cells grow, divide, and differentiate, we could instead assemble the cells using additive manufacturing techniques. And rather than building into each cell the ability to synthesize the energy it requires, we could simply feed energy into the system from an external source, much as we power a cell phone from a rechargeable battery or plug a computer into a wall outlet (via a power supply). Furthermore, we would not have to restrict ourselves to complete biological materials: it would be fine to 3D print some portions of the biomachine using conventional materials (e.g., plastics) and other parts using biomaterials (encapsulated as synthetic cells).

=== Why Are Synthetic Cells a Good Way to Get There? ===

[[Image:syncell_whitespace.png|400px|thumb|alt=DARPA white space chart|"White space" chart, showing a possible path to engineering biology at scale using synthetic cells. Figure courtesy Richard Murray, 2025 (CC BY).]]

One of the hypothesis of the synthetic cell movement is that building from the "bottom up" is more "engineerable" (predictable, robust, scaleable) than other approaches to building complex biomachines. The most obvious alternative is genetically modifying living organisms, and this is where the majority of work in synthetic biology currently takes place. But our record in engineering complex biological circuits and pathways in living organisms is not great: the most complex systems we have been able to to engineer to date have at most dozens of individually engineered components (see, for example, Srinivasan and Smolke, ''Science'', 2020<ref>P. Srinivasan and C. D. Smolke. [https://www.nature.com/articles/s41586-020-2650-9 "Biosynthesis of medicinal tropane alkaloids in yeast"]. ''Nature'' 585(7826):614–19, 2020. DOI: 10.1038/s41586-020-2650-9.</ref>), versus the millions of engineered components that are part of a cell phone, an airplane, or the power grid. One reason this might be the case is that when we engineer living systems, we are fighting against billions of years of evolution that have fine-tuned the organism we are engineering to carry out its specific function in nature, and we don't yet have the understanding or insight to modify that function in a way that is predictable, robust, and scaleable.

A major drawback of the synthetic cell approach versus more conventional approaches to engineering biology is that we have to re-invent all of the major subsystems from scratch. In particular, the need to "reinvent" metabolism is a major hurdle: natural cells come with the ability to metabolize carbon sources and turn them into energy and the other materials need for the cell to function. Synthetic cells must import the natural metabolic subsystem, reinvent metabolism, or find a different method for providing the power required to operate. The last approach seems to most plausible, but is an example of the significant challenges that must be overcome in order to make synthetic cells a viable alternative to genetically modified organisms.

=== More Achievable Starting Points (MVPs) ===

While building ants, plants, and slimes is perhaps a compelling long term vision, we are currently a long way from being able to achieve that. In the shorter term (2-10 years), here are a couple of examples of places synthetic cells might be useful on their own:

* '''Distributed Environmental Sensing, Recording, and Response''': Collections of developer cells that monitor and record or respond to environmental conditions could be built for applications ranging from human health to agriculture to surveillance. For example, imagine a synthetic cell that displays proteins or other complexes on its surface that allow it to bind to target niches, then monitor the local chemical, mechanical, optical, or thermal environment in that niche. Upon detection of a selected combination of signals, the synthetic cell could record events in DNA (eg, using conditionally activated integrases to alter DNA in a predefined way) and the DNA could later be sequenced to recover the signal(s) seen by the synthetic cells. Alternatively, the synthetic cell could produce and/or release a chemical or protein into the external environment to locally respond to the environmental event.

* '''Adaptive Materials Systems''': Building on some of the modules used for sensing, recording, and response, synthetic cells could be integrated with engineered materials to respond to environmental stimuli by modulating mechanical, chemical, or optical properties. For example, a collection of synthetic cells could be 3D printed to form a film with chemically- or thermally-reactive optical properties (e.g., changing reflectivity or color as a function of environmental cues, or tuning mechanical properties based on locally sensed events). The synthetic cells could be integrated with other materials (perhaps hydrogels or bioplastics) or with natural biofilms (for anti-fouling or biomanufacturing applications).

* '''Synthetic Cells as Replacements for EMERs'''. Engineered Microbes for Environmental Release (EMERs) are an emerging application area in synthetic biology with applications in agriculture, remediation, biomining, and therapeutics (animals or humans). EMERs can be challenging to use due to regulations governing the release of genetically modified organisms, in particular because they are often intended for open release, and so conventional containments strategies for genetically engineered organisms are not applicable. Replacing EMERs with (non-replicating) synthetic cells could provide a safer and more predictable method for carrying out existing biological functions such as nitrogen fixation, phenol degradation, or waste processing.

[[Synthetic cell demonstrations|Current demonstrations]] of synthetic cells are primarily oriented at demonstrating basic capabilities.

=== What About Recreating Life? ===

As noted above, one of the motivations for many people in the synthetic cell field is to better understand the rules of life and maybe even to create new forms of life. While this is a valiant goal, in this book we take the point of view that while we want to make use of the various biological components that nature has provided, the engineering approach to implementing useful functions using those biological components might be different than what nature has done. So just as airplanes make use of the same lift and draft mechanisms as birds but implement flight in very different ways, synthetic cells might make use of the same core mechanisms as biology (transcription, translation, enzymatic processing, etc) but not do so in a way that we would consider to be "living".

== Synthetic Cell Subsystems ==
[[Image:synthetic-cell-subsystems.png|right|400px|thumb|Conceptual diagrams of a synthetic cell, adapted from Del Vecchio and Murray<ref>D. Del Veccho and R. M. Murray, [https://press.princeton.edu/books/hardcover/9780691161532/biomolecular-feedback-systems ''Biomolecular Feedback Systems'']. Princeton University Press, 2014.</ref>.]]

We return now to the individual synthetic cell, and what is required to implement such a device as a building block for more complex biomachines.

We break of up our description of synthetic cells into a set of "subsystems" that are responsible for the primary molecular mechanisms of the cell. Each of these mechanisms is described in more detail on the linked page.

* '''Cytoplasm''': The [[Cytoplasm Subsystem]] is responsible for implementing and maintaining the internal environment of the synthetic cell, including key mechanisms such as transcription, translation, and degradation.
* '''Container''': The [[Container Subsystem]] is responsible for encapsulating the components of the synthetic cell, as well as supporting transfer of information and materials from the inside of the cell through the appropriate [[Sensing Subsystem|sensing]] and [[Transport Subsystem|transport]] subsystems.
* '''Sensing, Transport, and Communications''': The [[Sensing Subsystem]] is responsible for allowing the cell to obtain information about the external and internal environment. Sensed signals can include chemical concentrations, temperature, forces, light, or other biological, chemical, or physical entities. The [[Transport Subsystem]] is responsible for transporting materials across the synthetic cell boundary (membrane), either passively or actively, and will different levels of specificity. The [[Communications Subsystem]] is used to send information from one synthetic cell to another.
* '''Regulation and Logic''': The [[Regulation Subsystem]] maintains the internal environment of the cell and is responsible for providing robustness in the presence of uncertainty as well as allowing the design of the dynamics of the cell. The [[Logic Subsystem]] is responsible for implementing internal logic that can control the operations of the synthetic cell. In its simplest form, it carries out logical operations such as AND and OR functions, but more complex logic including finite state machines can also be used if needed.
* '''Metabolism''': The [[Metabolic Subsystem]] provides the energy required for the cell to operate. It can either consist of a mechanism for directly transferring energy from an external source or it can convert energy from one form into another.
* '''Motility and Adhesion''': The [[Motility Subsystem]] is responsible for generating forces in a what that allows a synthetic cell to move in its environment. The [[Adhesion Subsystem]] is used to attach a synthetic cell to other synthetic cells or other objects in the environment.

Which of these systems is present depends on the applications needs of the synthetic cell. We note that in the synthetic cells described here, we do not include a replication subsystem, since we are focused on non-replicating synthetic cells.

== Modeling and Specifications ==

[[Image:BioCRNpyler_Overview.png|thumb|400px|The hierarchical organization of classes in the BioCRNpyler framework. Arrows represent compilation. From https://biocrnpyler.readthedocs.org]]

Throughout this wiki, Python-based simulation models will be used to illustrate the dynamic characteristics of the subsystems and to build computational representations of interconnected subsystems. We will make use of the BioCRNpyler package<ref name="biocrnpyler">https://biocrnpyler.readthedocs.org. Retrieved 13 Sep 2025</ref>, a software framework and library designed to aid in the rapid construction of models from common motifs, such as molecular components, biochemical mechanisms and parameter sets. These parts can be reused and recombined to rapidly generate chemical reaction network (CRN) models in diverse chemical contexts at varying levels of model complexity.

BioCRNpyler compiles high-level specifications into detailed CRN models saved as SBML. Specifications may include: biomolecular components, modeling assumptions (mechanisms), biochemical context (mixtures), and parameters. BioCRNpyler is written in Python with a flexible object-oriented design, extensive documentation, and detailed examples to allow for easy model construction by modelers as well as customization and extension by developers. BioCRNpyler make use of the following abstractions (see the BioCRNpyler<ref name=biocrnpyler/> documentation for more details):

* '''Species''' and '''Reactions''' make up a CRN and are the output of BioCRNpyler compilation. Many sub-classes exist, such as ComplexSpecies and reactions with different kinds of rate function (e.g. mass-action, Hill functions, etc).

* '''Mechanisms''' are reaction schemas, which can be thought of as abstract functions that produce CRN Species and Reactions. They represent a particular molecular process, such as transcription or translation. During compilation, Mechanisms are called by Components. Global Mechanisms are called at the end of compilation in order to affect all species of a given type or with given attributes — for example, dilution of all protein Species.

* '''Components''' are reusable parts; they know what kinds of Mechanisms affect them but are agnostic to the underlying schema. For example, a promoter is a Component which will call a transcription Mechanism; similarly, a Ribosome Binding Site (RBS) is a Component which will call a translation Mechanism. However, the same Promoter and RBS can use many different transcription and translation Mechanisms depending on the modeling context and detail desired.

* '''Mixtures''' are sets of default Mechanisms and Components that represent different molecular and modeling contexts. As an example of molecular context, a cell-extract model requires reactions to consume a finite supply of fuel, while a steady-state model of living cells does not have a limited fuel supply. As an example of modeling context, a simple model of gene expression may have a gene catalytically create a protein product, while a more complex model might include cellular machinery such as RNA polymerase and ribosomes with Michaelis-Menten kinetics.

* '''Parameters''' are designed for flexibility; they can default to biophysically plausible values (such as a default binding rate), be shared between Components and Mechanisms, or have specific values for Component-Mechanism combinations. This system is designed so that models can be produced quickly without full knowledge of all parameters and then refined with detailed parameter files later.

== The Nucleus Developer Cell Platform ==

[[Image:bnext_devcell.png|400px|right|thumbnail|The Nucleus Developer Cell platform. Figure courtesy b.next.]]
Nucleus<ref>https://nucleus.bnext.bio. Retrieved 19 Jul 2025.</ref> is an open source platform for synthetic cell builders maintained by [https://bnext.bio b.next]—an SF-based startup company focused on rebuilding biology for engineering—that provides standardized protocols, design tools, component libraries, and reference designs for the full process of cell building. The platform encompasses comprehensive resources for cytosol construction, DNA content engineering, and membrane encapsulation, offering researchers a complete toolkit for developing functional synthetic cells. Currently in its fifth stable release (v0.3.0), Nucleus represents a systematic approach to making synthetic biology more accessible and standardized.

The Nucleus platform supports the development of various specialized synthetic cell types, including detector cells, emitter cells, and responder cells, enabling researchers to create cellular systems capable of molecular sensing and response. By providing both the integration architecture and practical materials needed for synthetic cell construction, Nucleus bridges the gap between conceptual design and actual implementation in synthetic biology research. The platform emphasizes open science principles with all materials freely shareable, fostering collaboration and transparency within the synthetic biology community. This open-source approach allows researchers worldwide to contribute to and benefit from the collective advancement of synthetic cell technology.

The Nucleus platform uses the OpenMTA<ref>https://www.openplant.org/openmta. Retrieved 19 Jul 2025.</ref> material transfer agreement, developed as a collaborative effort led by the BioBricks Foundation and OpenPlant, which allows open sharing of DNA with attribution (similar to an open source software license). Nucleus also uses the CERN Open Hardware License - Permission <ref> https://gitlab.com/ohwr/project/cernohl/-/wikis/uploads/3eff4154d05e7a0459f3ddbf0674cae4/cern_ohl_p_v2.txt. Retrieved 19 Jul 2025</ref> for distribution of modules and protocols. Documentation of Nucleus modules are done via Developer Notes<ref> https://devnotes.bnext.bio. Retrieved 19 Jul 2025</ref>, an open access, short form mechanism for scientific communication.

== References ==
<references />

Main Page

2025-09-13T04:40:04Z

Murray: /* Modeling and Specifications */

Welcome to the Synthetic Cell Wiki (SynCellWiki). This wiki contains information about synthetic cells and is intended as a reference manual for engineers who are interested in using synthetic cells to engineer biology.

== What is a Synthetic Cell? ==
[[Image:synthetic-cell-overview.jpg|right|400px|thumb|alt={Synthetic cell platforms}|
Four different molecular platforms for studying synthetic cells. ''ACS Synthetic Biology'', 13(4):974-997, 2024<ref name="Ros+2024:ACSsynbio"/>. CC BY-NC-ND.]]

The term "synthetic cell" is not well-defined and different groups have used it in different ways over time. Other terms are also used: artificial cells, developer cells, and protocells are some examples. What all of these definitions have in common is the notion of some sort of contained and engineered biomolecular machine that carries out functions similar to that of a living cell. Some of the major categories of synthetic cells include:

* '''Encapsulated cell-free systems''': A system consisting of a container of some sort, with biomolecular machinery inside the contained region that carries out biomolecular functions (transcription, translation, sensing, chemical processing, motility, etc). Synthetic cells in this class can range from very simple artificial vesicles containing a few proteins to complex biomolecular machines that carry out complex functions. As a general rule, synthetic cells in this category are not self-replicating, though they may include mechanisms for assembly into more complex consortia or multi-cellular machines.

* '''Biomimetic synthetic cells''': A system that carries the key functions of a living cell, typically including compartmentalization, replication, and metabolism. These systems do not yet exist, but significant progress has been made on each of the basic functions, often using encapusulated cell-free systems as a starting point. A recent review and roadmap for this class of systems has been written by members of the US Build-A-Cell<ref>https://buildacell.org. Retrieved 19 Jul 2025.</ref> consortium (Rosthschild et al, 2024<ref name="Ros+2024:ACSsynbio">L. J. Rothschild, N. J. H. Averesch, E. A. Strychalski, F. Moser, J. I. Glass, R. Cruz Perez, I. O. Yekinni, B. Rothschild-Mancinelli, G. A. Roberts Kingman, F. Wu, J. Waeterschoot, I. A. Ioannou, M. C. Jewett, A. P. Liu, V. Noireaux, C. Sorenson, and K. P. Adamala, [https://pubs.acs.org/doi/10.1021/acssynbio.3c00724 Building synthetic cells─From the technology infrastructure to cellular entities]. ''ACS Synthetic Biology'' 13(4):974-997, 2024. DOI: 10.1021/acssynbio.3c00724</ref>).

* '''Minimal cells''': A natural cell that has been heavily modified to utilize a minimized chromosome while still supporting life. The prototypical minimal cell is JCVI-syn3.0<ref>C. A. Hutchison III, R.-Y. Chuang, V. N. Noskov, N. Assad-Garcia, T. J. Deerinck, M. H. Ellisman, J. Gill, K. Kannan, B. J. Karas, L. Ma, J. F. Pelletier, Z.-Q. Qi, R. A. Richter, E. A. Strychalski, L. Sun, Y. Suzuki, B. Tsvetanova, K. S. Wise, H. O. Smith, J. I. Glass, C. Merryman, D. G. Gibson, and J. C. Venter, [https://www.science.org/doi/10.1126/science.aad6253 Design and synthesis of a minimal bacterial genome]. Science 351:aad6253, 2016. DOI:10.1126/science.aad6253</ref>, which consists of a modified ''Mycoplasma mycoides'' bacteria that has been modified to contain only 531,000 base pairs encoding 473 genes, making it the smallest genome of any self-replicating organism.

In this wiki, we will primarily focus on the technologies involved in the first two classes of synthetic cells, which are often referred to as "bottoms-up" synthetic cells, since they are built from non-living components.

== How Could Synthetic Cells Be Useful? ==

This section summarizes some of the potential applications for synthetic cells. The [[Synthetic Cell Applications]] page has a more detailed analysis of current and future applications of synthetic cells.

=== Long Term Vision: Building Biological Machines at Scale ===

[[Image:syncell-ant.png|right|240px|thumb|alt={Synthetic ants}|Carpenter ant, showing some of the different subsystems. CC BY-SA, [https://commons.wikimedia.org/wiki/File:Muurahainen.svg Jpant via Wikimedia Commons], 2006]]
A long term goal for synthetic cells is to enable predictable engineering of complex "biomachines", where a biomachine is an engineered system that makes use of biomolecules to carry out a useful function. For example, imagine a world in which engineers can design and build a device that is 1-2 mm long, operates for 24 hours, and can be programmed to explore small spaces and retrieve objects and substances with well-defined chemical, mechanical, or optical properties. In nature, this is called a carpenter ant, and it consists of ~20M cells that allow the ant to explore its environment, find food or building materials for its nest, and communicate with other ants. The various cells in the ant carry out different functions (muscles, energy conversion, sensing, decision making, etc.) and are assembled together in a fashion that allows the system to operate autonomously, much like a self-driving car is able navigate on city streets. While engineers are able to build self-driving cars, we have not yet developed and mastered the engineering processes and workflows needed to engineer a system at the millimeter scale that can carry out similarly useful functions.

[[Image:syncell-plant.png|left|240px|thumb|alt={Synthetic plants}|Conceptual synthetic plant, growing multiple fruits. Original figure courtesy LSU Ag Center, 2021]]
As a second example, imagine a biological machine that can extract chemicals and energy from the environment around it, transport the chemicals to processing centers where it combines and converts them into new molecules, and then transports them to packaging centers where its assembles them into a useful form. In nature, this is called an orange tree. The chemical engineering discipline can build machines that have these same high level functions (perhaps to produce chocolate oranges<ref>https://en.wikipedia.org/wiki/Terry%27s_Chocolate_Orange. Retrieved 19 Jul 2025.</ref> [invented in 1932!]), but we don't know how to build a biological machine at this level of complexity and function. If we could, we might even be able to engineer it so that it made different types of fruits on different branche (apples, oranges, and plums?), or build different variants of the machine that were tuned to operate in different types of climate (from rainforests to semi-arid plains, depending on the model that you choose).

[[Image:syncell-slime.png|right|240px|thumb|alt={Synthetic slimes (biofilms)}|Depiction of a biofilm. ARL CCDC, 2019.]]As a final example, and perhaps the most achievable in the near term, consider the idea of embedding synthetic cells into artificial and/or hybrid materials, similar to biofilms or perhaps slime molds. In this instantiation of synthetic, multicellular biomachines, the individual synthetic cells embedded in a material could sense conditions in their local environment and change the properties of the material in response to those conditions. For example, a material might adjust its mechanical or optical properties based on changes in temperature or chemical cues. Synthetic cells embedded in materials could also export chemicals to interact with the environment, perhaps degrading toxins or killing harmful organisms on the surface.

For all three of these cases (ants, plants, and slimes), synthetic cells are a possible starting point for many of the nanoscale and microscale functions that would need to be combined to produce these (multicellular) complex biomachines. Of course, there is no reason that these would need to mimic their natural counterparts completely. For example, rather than figuring out how to have cells grow, divide, and differentiate, we could instead assemble the cells using additive manufacturing techniques. And rather than building into each cell the ability to synthesize the energy it requires, we could simply feed energy into the system from an external source, much as we power a cell phone from a rechargeable battery or plug a computer into a wall outlet (via a power supply). Furthermore, we would not have to restrict ourselves to complete biological materials: it would be fine to 3D print some portions of the biomachine using conventional materials (e.g., plastics) and other parts using biomaterials (encapsulated as synthetic cells).

=== Why Are Synthetic Cells a Good Way to Get There? ===

[[Image:syncell_whitespace.png|400px|thumb|alt=DARPA white space chart|"White space" chart, showing a possible path to engineering biology at scale using synthetic cells. Figure courtesy Richard Murray, 2025 (CC BY).]]

One of the hypothesis of the synthetic cell movement is that building from the "bottom up" is more "engineerable" (predictable, robust, scaleable) than other approaches to building complex biomachines. The most obvious alternative is genetically modifying living organisms, and this is where the majority of work in synthetic biology currently takes place. But our record in engineering complex biological circuits and pathways in living organisms is not great: the most complex systems we have been able to to engineer to date have at most dozens of individually engineered components (see, for example, Srinivasan and Smolke, ''Science'', 2020<ref>P. Srinivasan and C. D. Smolke. [https://www.nature.com/articles/s41586-020-2650-9 "Biosynthesis of medicinal tropane alkaloids in yeast"]. ''Nature'' 585(7826):614–19, 2020. DOI: 10.1038/s41586-020-2650-9.</ref>), versus the millions of engineered components that are part of a cell phone, an airplane, or the power grid. One reason this might be the case is that when we engineer living systems, we are fighting against billions of years of evolution that have fine-tuned the organism we are engineering to carry out its specific function in nature, and we don't yet have the understanding or insight to modify that function in a way that is predictable, robust, and scaleable.

A major drawback of the synthetic cell approach versus more conventional approaches to engineering biology is that we have to re-invent all of the major subsystems from scratch. In particular, the need to "reinvent" metabolism is a major hurdle: natural cells come with the ability to metabolize carbon sources and turn them into energy and the other materials need for the cell to function. Synthetic cells must import the natural metabolic subsystem, reinvent metabolism, or find a different method for providing the power required to operate. The last approach seems to most plausible, but is an example of the significant challenges that must be overcome in order to make synthetic cells a viable alternative to genetically modified organisms.

=== More Achievable Starting Points (MVPs) ===

While building ants, plants, and slimes is perhaps a compelling long term vision, we are currently a long way from being able to achieve that. In the shorter term (2-10 years), here are a couple of examples of places synthetic cells might be useful on their own:

* '''Distributed Environmental Sensing, Recording, and Response''': Collections of developer cells that monitor and record or respond to environmental conditions could be built for applications ranging from human health to agriculture to surveillance. For example, imagine a synthetic cell that displays proteins or other complexes on its surface that allow it to bind to target niches, then monitor the local chemical, mechanical, optical, or thermal environment in that niche. Upon detection of a selected combination of signals, the synthetic cell could record events in DNA (eg, using conditionally activated integrases to alter DNA in a predefined way) and the DNA could later be sequenced to recover the signal(s) seen by the synthetic cells. Alternatively, the synthetic cell could produce and/or release a chemical or protein into the external environment to locally respond to the environmental event.

* '''Adaptive Materials Systems''': Building on some of the modules used for sensing, recording, and response, synthetic cells could be integrated with engineered materials to respond to environmental stimuli by modulating mechanical, chemical, or optical properties. For example, a collection of synthetic cells could be 3D printed to form a film with chemically- or thermally-reactive optical properties (e.g., changing reflectivity or color as a function of environmental cues, or tuning mechanical properties based on locally sensed events). The synthetic cells could be integrated with other materials (perhaps hydrogels or bioplastics) or with natural biofilms (for anti-fouling or biomanufacturing applications).

* '''Synthetic Cells as Replacements for EMERs'''. Engineered Microbes for Environmental Release (EMERs) are an emerging application area in synthetic biology with applications in agriculture, remediation, biomining, and therapeutics (animals or humans). EMERs can be challenging to use due to regulations governing the release of genetically modified organisms, in particular because they are often intended for open release, and so conventional containments strategies for genetically engineered organisms are not applicable. Replacing EMERs with (non-replicating) synthetic cells could provide a safer and more predictable method for carrying out existing biological functions such as nitrogen fixation, phenol degradation, or waste processing.

[[Synthetic cell demonstrations|Current demonstrations]] of synthetic cells are primarily oriented at demonstrating basic capabilities.

=== What About Recreating Life? ===

As noted above, one of the motivations for many people in the synthetic cell field is to better understand the rules of life and maybe even to create new forms of life. While this is a valiant goal, in this book we take the point of view that while we want to make use of the various biological components that nature has provided, the engineering approach to implementing useful functions using those biological components might be different than what nature has done. So just as airplanes make use of the same lift and draft mechanisms as birds but implement flight in very different ways, synthetic cells might make use of the same core mechanisms as biology (transcription, translation, enzymatic processing, etc) but not do so in a way that we would consider to be "living".

== Synthetic Cell Subsystems ==
[[Image:synthetic-cell-subsystems.png|right|400px|thumb|Conceptual diagrams of a synthetic cell, adapted from Del Vecchio and Murray<ref>D. Del Veccho and R. M. Murray, [https://press.princeton.edu/books/hardcover/9780691161532/biomolecular-feedback-systems ''Biomolecular Feedback Systems'']. Princeton University Press, 2014.</ref>.]]

We return now to the individual synthetic cell, and what is required to implement such a device as a building block for more complex biomachines.

We break of up our description of synthetic cells into a set of "subsystems" that are responsible for the primary molecular mechanisms of the cell. Each of these mechanisms is described in more detail on the linked page.

* '''Cytoplasm''': The [[Cytoplasm Subsystem]] is responsible for implementing and maintaining the internal environment of the synthetic cell, including key mechanisms such as transcription, translation, and degradation.
* '''Container''': The [[Container Subsystem]] is responsible for encapsulating the components of the synthetic cell, as well as supporting transfer of information and materials from the inside of the cell through the appropriate [[Sensing Subsystem|sensing]] and [[Transport Subsystem|transport]] subsystems.
* '''Sensing, Transport, and Communications''': The [[Sensing Subsystem]] is responsible for allowing the cell to obtain information about the external and internal environment. Sensed signals can include chemical concentrations, temperature, forces, light, or other biological, chemical, or physical entities. The [[Transport Subsystem]] is responsible for transporting materials across the synthetic cell boundary (membrane), either passively or actively, and will different levels of specificity. The [[Communications Subsystem]] is used to send information from one synthetic cell to another.
* '''Regulation and Logic''': The [[Regulation Subsystem]] maintains the internal environment of the cell and is responsible for providing robustness in the presence of uncertainty as well as allowing the design of the dynamics of the cell. The [[Logic Subsystem]] is responsible for implementing internal logic that can control the operations of the synthetic cell. In its simplest form, it carries out logical operations such as AND and OR functions, but more complex logic including finite state machines can also be used if needed.
* '''Metabolism''': The [[Metabolic Subsystem]] provides the energy required for the cell to operate. It can either consist of a mechanism for directly transferring energy from an external source or it can convert energy from one form into another.
* '''Motility and Adhesion''': The [[Motility Subsystem]] is responsible for generating forces in a what that allows a synthetic cell to move in its environment. The [[Adhesion Subsystem]] is used to attach a synthetic cell to other synthetic cells or other objects in the environment.

Which of these systems is present depends on the applications needs of the synthetic cell. We note that in the synthetic cells described here, we do not include a replication subsystem, since we are focused on non-replicating synthetic cells.

== Modeling and Specifications ==

[[Image:BioCRNpyler_Overview.png|thumb|400px|The hierarchical organization of classes in the BioCRNpyler framework. Arrows represent compilation. From https://biocrnpyler.readthedocs.org]]

Throughout this wiki, Python-based simulation models will be used to illustrate the dynamic characteristics of the subsystems and to build computational representations of interconnected subsystems. We will make use of the BioCRNpyler package<ref name="biocrnpyler">https://biocrnpyler.readthedocs.org. Retrieved 13 Sep 2025</ref>, a software framework and library designed to aid in the rapid construction of models from common motifs, such as molecular components, biochemical mechanisms and parameter sets. These parts can be reused and recombined to rapidly generate chemical reaction network (CRN) models in diverse chemical contexts at varying levels of model complexity.

BioCRNpyler compiles high-level specifications into detailed CRN models saved as SBML. Specifications may include: biomolecular Components, modeling assumptions (Mechanisms), biochemical context (Mixtures), and Parameters. BioCRNpyler is written in Python with a flexible object-oriented design, extensive documentation, and detailed examples to allow for easy model construction by modelers as well as customization and extension by developers. BioCRNpyler make use of the following abstractions (see the BioCRNpyler<ref name=biocrnpyler/> documentation for more details):

* '''Species''' and '''Reactions''' make up a CRN and are the output of BioCRNpyler compilation. Many sub-classes exist, such as ComplexSpecies and reactions with different kinds of rate function (e.g. mass-action, Hill functions, etc).

* '''Mechanisms''' are reaction schemas, which can be thought of as abstract functions that produce CRN Species and Reactions. They represent a particular molecular process, such as transcription or translation. During compilation, Mechanisms are called by Components. Global Mechanisms are called at the end of compilation in order to affect all species of a given type or with given attributes — for example, dilution of all protein Species.

* '''Components''' are reusable parts; they know what kinds of Mechanisms affect them but are agnostic to the underlying schema. For example, a promoter is a Component which will call a transcription Mechanism; similarly, a Ribosome Binding Site (RBS) is a Component which will call a translation Mechanism. However, the same Promoter and RBS can use many different transcription and translation Mechanisms depending on the modeling context and detail desired.

* '''Mixtures''' are sets of default Mechanisms and Components that represent different molecular and modeling contexts. As an example of molecular context, a cell-extract model requires reactions to consume a finite supply of fuel, while a steady-state model of living cells does not have a limited fuel supply. As an example of modeling context, a simple model of gene expression may have a gene catalytically create a protein product, while a more complex model might include cellular machinery such as RNA polymerase and ribosomes with Michaelis-Menten kinetics.

* '''Parameters''' are designed for flexibility; they can default to biophysically plausible values (such as a default binding rate), be shared between Components and Mechanisms, or have specific values for Component-Mechanism combinations. This system is designed so that models can be produced quickly without full knowledge of all parameters and then refined with detailed parameter files later.

== The Nucleus Developer Cell Platform ==

[[Image:bnext_devcell.png|400px|right|thumbnail|The Nucleus Developer Cell platform. Figure courtesy b.next.]]
Nucleus<ref>https://nucleus.bnext.bio. Retrieved 19 Jul 2025.</ref> is an open source platform for synthetic cell builders maintained by [https://bnext.bio b.next]—an SF-based startup company focused on rebuilding biology for engineering—that provides standardized protocols, design tools, component libraries, and reference designs for the full process of cell building. The platform encompasses comprehensive resources for cytosol construction, DNA content engineering, and membrane encapsulation, offering researchers a complete toolkit for developing functional synthetic cells. Currently in its fifth stable release (v0.3.0), Nucleus represents a systematic approach to making synthetic biology more accessible and standardized.

The Nucleus platform supports the development of various specialized synthetic cell types, including detector cells, emitter cells, and responder cells, enabling researchers to create cellular systems capable of molecular sensing and response. By providing both the integration architecture and practical materials needed for synthetic cell construction, Nucleus bridges the gap between conceptual design and actual implementation in synthetic biology research. The platform emphasizes open science principles with all materials freely shareable, fostering collaboration and transparency within the synthetic biology community. This open-source approach allows researchers worldwide to contribute to and benefit from the collective advancement of synthetic cell technology.

The Nucleus platform uses the OpenMTA<ref>https://www.openplant.org/openmta. Retrieved 19 Jul 2025.</ref> material transfer agreement, developed as a collaborative effort led by the BioBricks Foundation and OpenPlant, which allows open sharing of DNA with attribution (similar to an open source software license). Nucleus also uses the CERN Open Hardware License - Permission <ref> https://gitlab.com/ohwr/project/cernohl/-/wikis/uploads/3eff4154d05e7a0459f3ddbf0674cae4/cern_ohl_p_v2.txt. Retrieved 19 Jul 2025</ref> for distribution of modules and protocols. Documentation of Nucleus modules are done via Developer Notes<ref> https://devnotes.bnext.bio. Retrieved 19 Jul 2025</ref>, an open access, short form mechanism for scientific communication.

== References ==
<references />

Container Subsystem

2025-09-13T04:36:31Z

Murray:

The container subsystem is responsible for spatial organization of the synthetic cell. In its simplest form, it consists of a biocompatible material that encapsulates the cytoplasm. More complicated container subsystems might include additional internal spatial structure (localization, sub-compartments, etc). In some cases, the boundary of the container subsystem may not be completely distinct from the surrounding environment, as is the case with a condensate or other non-membrane-bound method of spatial organization.

== Vesicle-Based Systems ==

=== Phospholipid Vesicles ===

== Polymerosome-Based Systems ==

== Droplet-Based Systems ==

== Condensate-Based Systems ==

== Modeling and Specification ==
=== Implementation in BioCRNpyler ===

[[BioCRNpyler]] contains two separate capabilities that are needed for defining containers. The first is the ability to model separate compartments that contain isolated sets of chemical reactions. The second is a set of mechanisms for transport across membranes, including passive diffusion, pores, and transporters. This latter functionality is defined more careful in the [[Transport Subsystem]] chapter, and we focus here on the container functionality.

=== Subsystem specifications ===

[[Category:Subsystem]]

Synthetic Cell Applications

2025-09-13T04:33:34Z

Murray:

This page contains a summary of some of the applications of synthetic cells that have been described in the literature. This page focuses on "practical" applications; the [[synthetic cell demonstrations]] page focuses on proof-of-concept demonstrations. This page was generating using the following prompt to the [https://platform.futurehouse.org FutureHouse Falcon] deep search tool:

: I would like to get an explicit description of what has and can be done with synthetic cells (benefits), distinguishing between confined-use and open-environment applications, to prefigure risk distinctions later in the report. In particular, I would like to cover the following points:

: A. What has been done (doesn’t need to be a comprehensive review, but should explicitly state examples from different sectors/applications)

:: 1. Current state of synthetic cell R&D
:: 2. Applications in different sectors
:: 3. Applications in confined vs. open environments

: B. What could be done (speculative, but balanced/supported by evidence and avoiding hype) – emerging trends and future directions

:: 1. Innovation trajectories

:: 2. Democratization trajectory: falling costs may enable small‑lab or garage‑level construction; implications for oversight and surveillance.

:: 3. Drivers of R&D

:: 4. Possible points of inflection or disruption

:: 5. Potential “halo effects” — unintended positive externalities (e.g., ecosystem remediation side‑benefits).

The results were edit and rearranged by the page editors.

== Introduction ==

Synthetic cells—also known as artificial cells or protocells—are engineered membrane‐bound compartments designed to mimic one or more functions of natural cells. Such systems are typically built from defined molecular components including lipids, polymers, peptides, or even elastin‐like polypeptides, and have been constructed via bottom‑up, top‑down, or middle‑out methods <ref name="Sato2022">Synthetic cells in biomedical applications. Wakana Sato, Tomasz Zajkowski, Felix Moser, Katarzyna P. Adamala. WIREs Nanomedicine and Nanobiotechnology (2022). https://doi.org/10.1002/wnan.1761</ref>, <ref name="Rothschild2024">Building Synthetic Cells─From the Technology Infrastructure to Cellular Entities. Lynn J. Rothschild, Nils J. H. Averesch, Elizabeth A. Strychalski, Felix Moser, John I. Glass, Rolando Cruz Perez, Ibrahim O. Yekinni, Brooke Rothschild-Mancinelli, Garrett A. Roberts Kingman, Feilun Wu, Jorik Waeterschoot, Ion A. Ioannou, Michael C. Jewett, Allen P. Liu, Vincent Noireaux, Carlise Sorenson, Katarzyna P. Adamala. ACS Synthetic Biology (2024). https://doi.org/10.1021/acssynbio.3c00724</ref>. Many research groups have contributed foundational work in engineering these systems as both models for understanding life and platforms for practical applications <ref name="Rothschild2024" />, <ref name="Elani2021">Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology. Yuval Elani. Angewandte Chemie (2021). https://doi.org/10.1002/ange.202006941</ref>.

== Examples of Synthetic Cell Capabilities and Applications ==

=== Engineered Biochemical Reactors and Gene Expression Systems ===

One of the earliest and most significant achievements in synthetic cell research is the construction of cell‑sized compartments that recapitulate fundamental cellular processes such as gene expression, metabolic control, and even aspects of the cell cycle. For example, bottom‑up synthetic approaches have led to the assembly of minimal cell cycle circuits that incorporate key regulators such as cyclins and cyclin‑dependent kinases, enabling sustained biochemical oscillations within defined compartments <ref name="Groaz2021">Engineering spatiotemporal organization and dynamics in synthetic cells. Alessandro Groaz, Hossein Moghimianavval, Franco Tavella, Tobias W. Giessen, Anthony G. Vecchiarelli, Qiong Yang, Allen P. Liu. WIREs Nanomedicine and Nanobiotechnology (2021). https://doi.org/10.1002/wnan.1685</ref>. In many cases, these compartments are formed using giant unilamellar vesicles (GUVs) generated by techniques such as microfluidic synthesis, which allow for precise control over size, composition, and encapsulation efficiency <ref name="Elani2018">Constructing vesicle-based artificial cells with embedded living cells as organelle-like modules. Yuval Elani, Tatiana Trantidou, Douglas Wylie, Linda Dekker, Karen Polizzi, Robert V. Law, Oscar Ces. Scientific Reports (2018). https://doi.org/10.1038/s41598-018-22263-3</ref>, <ref name="Stano2018">Is Research on "Synthetic Cells" Moving to the Next Level?. Pasquale Stano. Life (2018). https://doi.org/10.3390/life9010003</ref>. Furthermore, cell‑free protein synthesis systems can be housed within such vesicles, enabling controlled gene expression and the production of functional proteins—a key step toward creating autonomous synthetic cells <ref name="Sato2022" />.

=== Biomedical Applications ===

Synthetic cells have been envisioned for a broad range of biomedical applications. In therapeutic contexts, they have been proposed to inhibit tumor growth by serving as microreactors that produce antimicrobial peptides or anti‑cancer proteins in response to external stimuli <ref name="Sato2022" />, <ref name="Elani2021" />. Several studies have demonstrated that synthetic vesicles can act as potential vehicles for drug delivery, wherein controlled release mechanisms—triggered by light, magnetic fields, or changes in pH—enable targeted therapies that minimize off‑target effects <ref name="Rothschild2024" />, <ref name="Elani2021" />. In addition, hybrid systems have been constructed in which living cells are encapsulated within synthetic membranes; such "embedded hybrid" configurations protect the natural cells from otherwise toxic environments while also providing additional functionalities such as bioenergetic support through photosynthetic or chromatophore‑based modules <ref name="Elani2018" />, <ref name="Elani2021" />. Researchers have also demonstrated that synthetic cells can interact with natural cells via two‑way communication pathways, indicating their potential to serve as artificial organelles or "cellular implants" that modulate biological processes such as immune responses or tissue regeneration <ref name="Groaz2021" />, <ref name="Rothschild2024" />.

=== Applications in Biosensing, Diagnostic, and Environmental Technologies ===

Synthetic cells have been developed as advanced biosensors and diagnostic platforms. Their engineered compartmentalization enables the isolation and quantification of biochemical reactions that are triggered by specific metabolites or molecular signals. For instance, constructed synthetic vesicles have been used to monitor lactate levels or detect quorum sensing signals from bacterial populations, effectively translating molecular information into detectable outputs <ref name="Smith2022">Controlling Synthetic Cell-Cell Communication. Jefferson M. Smith, Razia Chowdhry, Michael J. Booth. Frontiers in Molecular Biosciences (2022). https://doi.org/10.3389/fmolb.2021.809945</ref>, <ref name="Rothschild2024" />. In the environmental domain, synthetic cell systems are being explored to replace chemical fertilizers, tailor plant microbiomes, and improve bioremediation processes by surviving in harsh conditions and acting on synthetic compounds <ref name="Rothschild2024" />. Such platforms offer significant advantages over natural cells given their defined composition and inherent biosafety, which minimizes risks of uncontrolled proliferation in open environments <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Applications in Confined (In Vitro) vs. Open (In Vivo) Environments ===

In tightly controlled laboratory settings, synthetic cells have predominantly been utilized as model systems to dissect cellular processes under precisely defined conditions. Studies conducted using liposome‑ or polymersome‑based compartments have provided insight into enzyme kinetics, genetic circuit operation, and reaction network behaviors, often utilizing microfluidic techniques to ensure monodispersity and reproducibility <ref name="Groaz2021" />, <ref name="Stano2018" />. By contrast, application in open environments—such as for therapeutic delivery or environmental remediation—presents additional challenges that have been addressed through hybrid strategies. For example, synthetic vesicles that interface with natural cells have been tailored to exhibit robust stability and environmental responsiveness, allowing them to operate in the dynamic and less predictable conditions encountered in vivo or in nature <ref name="Elani2021" />, <ref name="Rothschild2024" />. In some cases, the integration of living cell modules within artificial cells has been exploited as a means to endow these systems with adaptive properties that are otherwise challenging to achieve in entirely synthetic constructs <ref name="Elani2018" />, <ref name="Rothschild2024" />.

=== Materials and Methodologies in Synthetic Cell Construction ===

Synthetic cell membranes themselves are engineered from a variety of materials, each with distinct advantages and limitations. Phospholipid membranes remain a widely used platform because they closely mimic natural cell membranes and are highly compatible with membrane proteins; however, their mechanical fragility can limit their application in dynamic or harsh environments <ref name="Groaz2021" />, <ref name="Rothschild2024" />. In response, researchers have increasingly employed alternative materials such as block copolymers—which produce polymersomes—and elastin‑like polypeptides (ELPs) that yield more robust synthetic membranes <ref name="Elani2021" />, <ref name="Elani2018" />. The latter systems not only demonstrate improved stability under osmotic and chemical stress but also enable dynamic remodeling of the membrane by incorporating newly expressed peptides via cell‑free expression <ref name="Elani2018" />, <ref name="Elani2021" />. These material innovations are foundational for both fundamental studies and translational applications, as they expand the operational window of synthetic cells in diverse environments.

== Potential Future Directions and Emerging Trends ==

=== Innovation Trajectories in Synthetic Cell Development ===

Emerging research trends suggest that the field of synthetic cells is poised for continual innovation toward constructing systems that display increased autonomy and complexity. One of the major future directions is the development of synthetic cells that not only encapsulate biochemical reactions but also exhibit self‑sustained processes such as growth, division, and evolution. Current efforts on minimal cell cycle circuits and feedback network systems lay the groundwork for achieving autonomous replication and self‑maintenance, with theoretical models (e.g., the "ideal synthetic cell" concept) pointing toward future realizations where the phenotype can be predicted directly from genotype <ref name="Sato2022" />, <ref name="Rothschild2024" />. This line of research is supported by experiments in which synthetic cells incorporate metabolic modules—such as those enabling light‑driven ATP synthesis or NAD regeneration—thereby providing the necessary energy for sustained biochemical activity <ref name="Groaz2021" />, <ref name="Devaraj2021">Synthesis of lipid membranes for artificial cells. Kira A. Podolsky, Neal K. Devaraj. Nature Reviews Chemistry (2021). https://doi.org/10.1038/s41570-021-00303-3</ref>. Over the next decade it is conceivable that further integration of genetic circuits with robust metabolic networks will lead to synthetic cells that can undergo controlled division cycles and adapt via evolutionary processes, offering a new paradigm for understanding the transition from chemistry to biology <ref name="Rothschild2024" />.

Beyond the reproduction of basic life processes, future synthetic cells may incorporate advanced sensing and communication capabilities that enable them to function as intelligent therapeutic systems. For instance, integration of optogenetic tools and synthetic RNA thermometers could allow spatiotemporally controlled expression of therapeutic proteins and facilitate on‑demand activation of cellular responses in vivo <ref name="Elani2021" />, <ref name="VanRaad2021">In Vitro Protein Synthesis in Semipermeable Artificial Cells. Damian Van Raad, Thomas Huber. ACS Synthetic Biology (2021). https://doi.org/10.1021/acssynbio.1c00044</ref>. Moreover, recent work on chemically programmed cell–cell communication has demonstrated that synthetic cells can be engineered to engage in two‑way information exchange with natural cells, thus paving the way for sophisticated hybrid interfaces that integrate living tissue with artificial constructs <ref name="Elani2021" />, <ref name="Smith2022" />. These advances may ultimately converge in the development of synthetic cells capable of coordinating with biological systems in a "cyber‑biological" network that responds to physiological cues with high specificity and precision <ref name="Rothschild2024" />.

=== Democratization Trajectory and the Implications for Oversight ===

An important emerging trend is the falling cost of DNA synthesis, cell‑free expression systems, and microfluidic fabrication methods, which collectively are lowering the barriers to entry for synthetic cell engineering. The rapid progress in open‑source biotechnology is democratizing access to these technologies, making it increasingly feasible for small academic labs and even decentralized "garage‑level" operations to build and experiment with synthetic cells <ref name="Sato2022" />, <ref name="Rothschild2024" />. This democratization holds great promise for accelerating innovation and fostering a more decentralized approach to discovery; however, it also raises critical issues of oversight and biosafety. The ease of constructing programmable synthetic cells may necessitate new frameworks for regulation and risk assessment to ensure that such constructs, when deployed in open environments, do not inadvertently disrupt natural ecosystems or pose security risks <ref name="Sato2022" />, <ref name="Rothschild2024" />.

One potential response to these challenges is the development of intrinsic biosafety measures, such as the integration of kill switches or "containment devices" that render synthetic cells incapable of sustained proliferation outside controlled environments <ref name="Sato2022" />, <ref name="Gobbo2020">From protocells to prototissues: a materials chemistry approach. Pierangelo Gobbo. Biochemical Society Transactions (2020). https://doi.org/10.1042/bst20200310</ref>. Moreover, the open‑source sharing of protocols and negative results—as encouraged by some in the community—could lead to more standardized safety practices and accelerated troubleshooting of potential hazards <ref name="Rothschild2024" />. In this way, the democratization of synthetic cell technology may not only spur innovation but also drive the creation of community‑based regulatory frameworks aimed at minimizing risks while ensuring positive externalities.

=== Key Drivers of Research and Development ===

Several technological and conceptual drivers are fueling rapid progress in the synthetic cell space. Foremost among these is the advancement in microfluidic platforms, which enable high‑throughput and precise generation of cell‑sized compartments with controlled composition and reproducibility <ref name="Elani2018" />, <ref name="Stano2018" />. These platforms not only permit the creation of robust vesicles but also enable intricate spatial arrangement and temporal control of biochemical reactions within synthetic cells <ref name="Rothschild2024" />.

Another crucial driver is the maturation of cell‑free protein synthesis technologies that are essential for the internal functioning of synthetic cells. The continued refinement of orthogonal translation systems and genetic code expansion techniques allows for the production of non‑canonical proteins and enzymes that may endow synthetic cells with novel functionalities not present in natural organisms <ref name="Sato2022" />. Additionally, innovations in membrane engineering—ranging from the use of natural phospholipids to robust synthetic polymers and peptide‑based membranes—are expanding the operational range and stability of synthetic cells, making them more suitable for practical applications in harsh or dynamic environments <ref name="Groaz2021" />, <ref name="Elani2018" />. These technological improvements are complemented by computational modeling and agent‑based simulations, which provide predictive frameworks for complex reaction networks and help researchers optimize synthetic cell designs prior to experimental implementation <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Points of Inflection and Potential Disruptive Moments ===

The field of synthetic cells is approaching several potential points of inflection. One such inflection point lies in achieving full self‑reproduction and autonomous cell division within synthetic constructs. Despite significant progress, most current synthetic cells require external energy inputs and careful control to sustain metabolic activities; a breakthrough in developing self‑sustaining replication would mark a dramatic shift toward fully "living" synthetic cells <ref name="Sato2022" />. Such progress could trigger a cascade of additional innovations, including open‑ended evolution, whereby synthetic cells could adapt and optimize their functions in response to environmental stimuli <ref name="Rothschild2024" />, <ref name="Devaraj2021" />.

Another potential disruption is the integration of synthetic cells with electronic and digital technologies to create hybrid bioelectronic devices. For instance, coupling synthetic cells with optogenetic control systems or nanostructured sensors could enable real‑time monitoring and precise modulation of cellular functions, opening up novel applications in diagnostics, targeted therapy, and biomanufacturing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />. Such convergence of biotechnology with information technology is likely to generate platforms that are far more responsive and adaptable than current systems.

Furthermore, the ongoing convergence between synthetic biology and materials science may lead to the development of programmable "smart" surfaces and biohybrid materials that incorporate synthetic cells as active elements. These materials could be designed to self‑heal, dynamically respond to economic or environmental stressors, or even mediate communication between disparate biological systems, thereby revolutionizing fields such as regenerative medicine, soft robotics, and environmental remediation <ref name="Rothschild2024" />.

=== Potential "Halo Effects" and Unintended Positive Externalities ===

Beyond their direct applications, synthetic cells have the potential to generate broad societal benefits that extend well beyond their immediate technological impact. For example, the development of robust synthetic cells for biomanufacturing could lead to alternative production platforms for pharmaceuticals, enzymes, and biomaterials that are more sustainable and less resource‑intensive than traditional cell‑based production methods <ref name="Sato2022" />, <ref name="Rothschild2024" />. In the environmental arena, synthetic cells designed for detoxification or pollutant sequestration could contribute to ecosystem remediation efforts by breaking down plastics, heavy metals, or organic contaminants in situ <ref name="Rothschild2024" />.

Moreover, the cross‑disciplinary innovations that underlie synthetic cell technology are likely to have "halo effects" in adjacent fields. Advances in high‑precision microfluidics and membrane engineering, for instance, are directly applicable to the fabrication of nanoscale devices and diagnostic sensors, thereby accelerating progress in nanomedicine and point‑of‑care diagnostics <ref name="Elani2018" />, <ref name="Stano2018" />. In academic settings, the relatively low cost and modularity of synthetic cell systems may inspire a new generation of bioengineers and chemists to explore the fundamentals of life in an open‑source and distributed manner, further democratizing science while fostering innovation in education and research <ref name="Sato2022" />, <ref name="Rothschild2024" />.

In addition, the ethical and regulatory discussions catalyzed by the increasing accessibility of synthetic cell technologies may lead to more robust oversight frameworks that protect public health and the environment while simultaneously encouraging safe innovation <ref name="Sato2022" />, <ref name="Rothschild2024" />. The increased emphasis on biosafety, kill switches, and built‑in containment measures—not only for synthetic cells but for related gene‑editing and synthetic biology applications—has the potential to elevate standards across the board and reduce risk in both industrial and academic settings.

== Summary and Conclusions ==

The field of synthetic cells has demonstrated significant progress across a wide spectrum of applications. Researchers have built platforms that mimic crucial features of natural cells such as compartmentalization, metabolism, gene expression, and communication. In vitro models have enabled precise investigations of biochemical processes, while hybrid systems that interface synthetic cells with natural cells have shown promise in therapeutic, diagnostic, and environmental applications <ref name="Elani2021" />, <ref name="Groaz2021" />, <ref name="Rothschild2024" />. The evolution of biomimetic membranes—from conventional phospholipid vesicles to robust elastin‑like polypeptide and polymersome systems—has broadened the operational envelope of synthetic cells, enabling their use both in controlled laboratory conditions and in more dynamic, open environments <ref name="Groaz2021" />, <ref name="Elani2018" />.

Looking forward, several key innovation trajectories are likely to transform synthetic cell technology. The drive toward achieving autonomous self‑reproduction and complex metabolic integration in synthetic cells represents perhaps the most fundamental challenge, with breakthroughs in these areas promising to create systems that effectively blur the line between non‑living engineered constructs and living organisms <ref name="Sato2022" />. Concurrently, the rapid democratization of biotechnological tools—including low‑cost DNA synthesis and robust cell‑free expression systems—is poised to make the construction of synthetic cells accessible not only to well‑funded laboratories but also to smaller research groups and possibly citizen scientists, a development that will necessitate careful oversight and updated regulatory frameworks <ref name="Rothschild2024" />.

Key drivers of current and future research include advanced microfluidic fabrication techniques, improved membrane engineering and material choices, and enhanced cell‑free systems that support sophisticated gene circuits. These tools provide the means for building increasingly intricate synthetic cells that can serve as platforms in biomedicine, environmental remediation, biomimetic robotics, and sustainable biomanufacturing <ref name="Elani2018" />, <ref name="Stano2018" />, <ref name="Sato2022" />. In addition, the integration of synthetic cells with digital and electronic control systems may give rise to hybrid bioelectronic devices that markedly improve the precision of drug delivery and diagnostic sensing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />.

Moreover, as synthetic cell technology further matures, unintended yet positive externalities are likely to emerge. The same innovations that enable the creation of minimal cell‑like systems could lead to new strategies for ecosystem remediation by deploying synthetic cells that degrade pollutants or sequester heavy metals in contaminated environments <ref name="Rothschild2024" />. In biomanufacturing, synthetic cells may provide scalable and highly controlled platforms for the production of high‑value compounds, reducing reliance on natural organisms that are often constrained by slower growth rates and more complex regulatory networks <ref name="Rothschild2024" />.

Overall, synthetic cell research is advancing along multiple convergent trajectories that are transforming both our understanding of life and the technologies that control biological processes. The integration of multidisciplinary approaches—from materials science and microfluidics to cell‑free synthetic biology and computational modeling—is fostering a rich environment for innovation. Groups such as those led by Adamala, Kamat, Booth, Elani, Liu, Deveraj, and Schwille continue to push the boundaries of what can be achieved with synthetic cells, demonstrating practical applications that span medicine, biotechnology, environmental science, and beyond <ref name="Elani2023">What it means to be alive: a synthetic cell perspective. Yuval Elani, John M. Seddon. Interface Focus (2023). https://doi.org/10.1098/rsfs.2023.0036</ref>, <ref name="Elani2021" />.

In conclusion, the current state of synthetic cell R&D is characterized by stepwise progress in creating well‑defined, functional cell‑mimics that have already provided useful insights into fundamental biological processes and have been applied in a variety of sectors. Looking forward, further integrating metabolic, regulatory, and replicative functions within synthetic cells will likely yield platforms that are increasingly autonomous and life‑like. This will open up transformative applications across drug delivery, biosensing, regenerative medicine, and environmental remediation, while also posing important challenges in governance, safety, and ethical oversight. As costs continue to decline and technical accessibility improves, the democratization of synthetic cell technology promises to unleash a new era of innovation that could have far‑reaching "halo effects" well beyond the confines of synthetic biology itself <ref name="Sato2022" />, <ref name="Rothschild2024" />.

== References ==
<references />

Synthetic Cell Applications

2025-09-12T23:45:52Z

Murray:

This page contains a summary of some of the applications of synthetic cells that have been described in the literature. This page focuses on "practical" applications; the [synthetic cell demonstrations] page focuses on proof-of-concept demonstrations. This page was generating using the following prompt to the [https://platform.futurehouse.org FutureHouse Falcon] deep search tool:

: I would like to get an explicit description of what has and can be done with synthetic cells (benefits), distinguishing between confined-use and open-environment applications, to prefigure risk distinctions later in the report. In particular, I would like to cover the following points:

: A. What has been done (doesn’t need to be a comprehensive review, but should explicitly state examples from different sectors/applications)

:: 1. Current state of synthetic cell R&D
:: 2. Applications in different sectors
:: 3. Applications in confined vs. open environments

: B. What could be done (speculative, but balanced/supported by evidence and avoiding hype) – emerging trends and future directions

:: 1. Innovation trajectories

:: 2. Democratization trajectory: falling costs may enable small‑lab or garage‑level construction; implications for oversight and surveillance.

:: 3. Drivers of R&D

:: 4. Possible points of inflection or disruption

:: 5. Potential “halo effects” — unintended positive externalities (e.g., ecosystem remediation side‑benefits).

The results were edit and rearranged by the page editors.

== Introduction ==

Synthetic cells—also known as artificial cells or protocells—are engineered membrane‐bound compartments designed to mimic one or more functions of natural cells. Such systems are typically built from defined molecular components including lipids, polymers, peptides, or even elastin‐like polypeptides, and have been constructed via bottom‑up, top‑down, or middle‑out methods <ref name="Sato2022">Synthetic cells in biomedical applications. Wakana Sato, Tomasz Zajkowski, Felix Moser, Katarzyna P. Adamala. WIREs Nanomedicine and Nanobiotechnology (2022). https://doi.org/10.1002/wnan.1761</ref>, <ref name="Rothschild2024">Building Synthetic Cells─From the Technology Infrastructure to Cellular Entities. Lynn J. Rothschild, Nils J. H. Averesch, Elizabeth A. Strychalski, Felix Moser, John I. Glass, Rolando Cruz Perez, Ibrahim O. Yekinni, Brooke Rothschild-Mancinelli, Garrett A. Roberts Kingman, Feilun Wu, Jorik Waeterschoot, Ion A. Ioannou, Michael C. Jewett, Allen P. Liu, Vincent Noireaux, Carlise Sorenson, Katarzyna P. Adamala. ACS Synthetic Biology (2024). https://doi.org/10.1021/acssynbio.3c00724</ref>. Many research groups have contributed foundational work in engineering these systems as both models for understanding life and platforms for practical applications <ref name="Rothschild2024" />, <ref name="Elani2021">Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology. Yuval Elani. Angewandte Chemie (2021). https://doi.org/10.1002/ange.202006941</ref>.

== Examples of Synthetic Cell Capabilities and Applications ==

=== Engineered Biochemical Reactors and Gene Expression Systems ===

One of the earliest and most significant achievements in synthetic cell research is the construction of cell‑sized compartments that recapitulate fundamental cellular processes such as gene expression, metabolic control, and even aspects of the cell cycle. For example, bottom‑up synthetic approaches have led to the assembly of minimal cell cycle circuits that incorporate key regulators such as cyclins and cyclin‑dependent kinases, enabling sustained biochemical oscillations within defined compartments <ref name="Groaz2021">Engineering spatiotemporal organization and dynamics in synthetic cells. Alessandro Groaz, Hossein Moghimianavval, Franco Tavella, Tobias W. Giessen, Anthony G. Vecchiarelli, Qiong Yang, Allen P. Liu. WIREs Nanomedicine and Nanobiotechnology (2021). https://doi.org/10.1002/wnan.1685</ref>. In many cases, these compartments are formed using giant unilamellar vesicles (GUVs) generated by techniques such as microfluidic synthesis, which allow for precise control over size, composition, and encapsulation efficiency <ref name="Elani2018">Constructing vesicle-based artificial cells with embedded living cells as organelle-like modules. Yuval Elani, Tatiana Trantidou, Douglas Wylie, Linda Dekker, Karen Polizzi, Robert V. Law, Oscar Ces. Scientific Reports (2018). https://doi.org/10.1038/s41598-018-22263-3</ref>, <ref name="Stano2018">Is Research on "Synthetic Cells" Moving to the Next Level?. Pasquale Stano. Life (2018). https://doi.org/10.3390/life9010003</ref>. Furthermore, cell‑free protein synthesis systems can be housed within such vesicles, enabling controlled gene expression and the production of functional proteins—a key step toward creating autonomous synthetic cells <ref name="Sato2022" />.

=== Biomedical Applications ===

Synthetic cells have been envisioned for a broad range of biomedical applications. In therapeutic contexts, they have been proposed to inhibit tumor growth by serving as microreactors that produce antimicrobial peptides or anti‑cancer proteins in response to external stimuli <ref name="Sato2022" />, <ref name="Elani2021" />. Several studies have demonstrated that synthetic vesicles can act as potential vehicles for drug delivery, wherein controlled release mechanisms—triggered by light, magnetic fields, or changes in pH—enable targeted therapies that minimize off‑target effects <ref name="Rothschild2024" />, <ref name="Elani2021" />. In addition, hybrid systems have been constructed in which living cells are encapsulated within synthetic membranes; such "embedded hybrid" configurations protect the natural cells from otherwise toxic environments while also providing additional functionalities such as bioenergetic support through photosynthetic or chromatophore‑based modules <ref name="Elani2018" />, <ref name="Elani2021" />. Researchers have also demonstrated that synthetic cells can interact with natural cells via two‑way communication pathways, indicating their potential to serve as artificial organelles or "cellular implants" that modulate biological processes such as immune responses or tissue regeneration <ref name="Groaz2021" />, <ref name="Rothschild2024" />.

=== Applications in Biosensing, Diagnostic, and Environmental Technologies ===

Synthetic cells have been developed as advanced biosensors and diagnostic platforms. Their engineered compartmentalization enables the isolation and quantification of biochemical reactions that are triggered by specific metabolites or molecular signals. For instance, constructed synthetic vesicles have been used to monitor lactate levels or detect quorum sensing signals from bacterial populations, effectively translating molecular information into detectable outputs <ref name="Smith2022">Controlling Synthetic Cell-Cell Communication. Jefferson M. Smith, Razia Chowdhry, Michael J. Booth. Frontiers in Molecular Biosciences (2022). https://doi.org/10.3389/fmolb.2021.809945</ref>, <ref name="Rothschild2024" />. In the environmental domain, synthetic cell systems are being explored to replace chemical fertilizers, tailor plant microbiomes, and improve bioremediation processes by surviving in harsh conditions and acting on synthetic compounds <ref name="Rothschild2024" />. Such platforms offer significant advantages over natural cells given their defined composition and inherent biosafety, which minimizes risks of uncontrolled proliferation in open environments <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Applications in Confined (In Vitro) vs. Open (In Vivo) Environments ===

In tightly controlled laboratory settings, synthetic cells have predominantly been utilized as model systems to dissect cellular processes under precisely defined conditions. Studies conducted using liposome‑ or polymersome‑based compartments have provided insight into enzyme kinetics, genetic circuit operation, and reaction network behaviors, often utilizing microfluidic techniques to ensure monodispersity and reproducibility <ref name="Groaz2021" />, <ref name="Stano2018" />. By contrast, application in open environments—such as for therapeutic delivery or environmental remediation—presents additional challenges that have been addressed through hybrid strategies. For example, synthetic vesicles that interface with natural cells have been tailored to exhibit robust stability and environmental responsiveness, allowing them to operate in the dynamic and less predictable conditions encountered in vivo or in nature <ref name="Elani2021" />, <ref name="Rothschild2024" />. In some cases, the integration of living cell modules within artificial cells has been exploited as a means to endow these systems with adaptive properties that are otherwise challenging to achieve in entirely synthetic constructs <ref name="Elani2018" />, <ref name="Rothschild2024" />.

=== Materials and Methodologies in Synthetic Cell Construction ===

Synthetic cell membranes themselves are engineered from a variety of materials, each with distinct advantages and limitations. Phospholipid membranes remain a widely used platform because they closely mimic natural cell membranes and are highly compatible with membrane proteins; however, their mechanical fragility can limit their application in dynamic or harsh environments <ref name="Groaz2021" />, <ref name="Rothschild2024" />. In response, researchers have increasingly employed alternative materials such as block copolymers—which produce polymersomes—and elastin‑like polypeptides (ELPs) that yield more robust synthetic membranes <ref name="Elani2021" />, <ref name="Elani2018" />. The latter systems not only demonstrate improved stability under osmotic and chemical stress but also enable dynamic remodeling of the membrane by incorporating newly expressed peptides via cell‑free expression <ref name="Elani2018" />, <ref name="Elani2021" />. These material innovations are foundational for both fundamental studies and translational applications, as they expand the operational window of synthetic cells in diverse environments.

== Potential Future Directions and Emerging Trends ==

=== Innovation Trajectories in Synthetic Cell Development ===

Emerging research trends suggest that the field of synthetic cells is poised for continual innovation toward constructing systems that display increased autonomy and complexity. One of the major future directions is the development of synthetic cells that not only encapsulate biochemical reactions but also exhibit self‑sustained processes such as growth, division, and evolution. Current efforts on minimal cell cycle circuits and feedback network systems lay the groundwork for achieving autonomous replication and self‑maintenance, with theoretical models (e.g., the "ideal synthetic cell" concept) pointing toward future realizations where the phenotype can be predicted directly from genotype <ref name="Sato2022" />, <ref name="Rothschild2024" />. This line of research is supported by experiments in which synthetic cells incorporate metabolic modules—such as those enabling light‑driven ATP synthesis or NAD regeneration—thereby providing the necessary energy for sustained biochemical activity <ref name="Groaz2021" />, <ref name="Devaraj2021">Synthesis of lipid membranes for artificial cells. Kira A. Podolsky, Neal K. Devaraj. Nature Reviews Chemistry (2021). https://doi.org/10.1038/s41570-021-00303-3</ref>. Over the next decade it is conceivable that further integration of genetic circuits with robust metabolic networks will lead to synthetic cells that can undergo controlled division cycles and adapt via evolutionary processes, offering a new paradigm for understanding the transition from chemistry to biology <ref name="Rothschild2024" />.

Beyond the reproduction of basic life processes, future synthetic cells may incorporate advanced sensing and communication capabilities that enable them to function as intelligent therapeutic systems. For instance, integration of optogenetic tools and synthetic RNA thermometers could allow spatiotemporally controlled expression of therapeutic proteins and facilitate on‑demand activation of cellular responses in vivo <ref name="Elani2021" />, <ref name="VanRaad2021">In Vitro Protein Synthesis in Semipermeable Artificial Cells. Damian Van Raad, Thomas Huber. ACS Synthetic Biology (2021). https://doi.org/10.1021/acssynbio.1c00044</ref>. Moreover, recent work on chemically programmed cell–cell communication has demonstrated that synthetic cells can be engineered to engage in two‑way information exchange with natural cells, thus paving the way for sophisticated hybrid interfaces that integrate living tissue with artificial constructs <ref name="Elani2021" />, <ref name="Smith2022" />. These advances may ultimately converge in the development of synthetic cells capable of coordinating with biological systems in a "cyber‑biological" network that responds to physiological cues with high specificity and precision <ref name="Rothschild2024" />.

=== Democratization Trajectory and the Implications for Oversight ===

An important emerging trend is the falling cost of DNA synthesis, cell‑free expression systems, and microfluidic fabrication methods, which collectively are lowering the barriers to entry for synthetic cell engineering. The rapid progress in open‑source biotechnology is democratizing access to these technologies, making it increasingly feasible for small academic labs and even decentralized "garage‑level" operations to build and experiment with synthetic cells <ref name="Sato2022" />, <ref name="Rothschild2024" />. This democratization holds great promise for accelerating innovation and fostering a more decentralized approach to discovery; however, it also raises critical issues of oversight and biosafety. The ease of constructing programmable synthetic cells may necessitate new frameworks for regulation and risk assessment to ensure that such constructs, when deployed in open environments, do not inadvertently disrupt natural ecosystems or pose security risks <ref name="Sato2022" />, <ref name="Rothschild2024" />.

One potential response to these challenges is the development of intrinsic biosafety measures, such as the integration of kill switches or "containment devices" that render synthetic cells incapable of sustained proliferation outside controlled environments <ref name="Sato2022" />, <ref name="Gobbo2020">From protocells to prototissues: a materials chemistry approach. Pierangelo Gobbo. Biochemical Society Transactions (2020). https://doi.org/10.1042/bst20200310</ref>. Moreover, the open‑source sharing of protocols and negative results—as encouraged by some in the community—could lead to more standardized safety practices and accelerated troubleshooting of potential hazards <ref name="Rothschild2024" />. In this way, the democratization of synthetic cell technology may not only spur innovation but also drive the creation of community‑based regulatory frameworks aimed at minimizing risks while ensuring positive externalities.

=== Key Drivers of Research and Development ===

Several technological and conceptual drivers are fueling rapid progress in the synthetic cell space. Foremost among these is the advancement in microfluidic platforms, which enable high‑throughput and precise generation of cell‑sized compartments with controlled composition and reproducibility <ref name="Elani2018" />, <ref name="Stano2018" />. These platforms not only permit the creation of robust vesicles but also enable intricate spatial arrangement and temporal control of biochemical reactions within synthetic cells <ref name="Rothschild2024" />.

Another crucial driver is the maturation of cell‑free protein synthesis technologies that are essential for the internal functioning of synthetic cells. The continued refinement of orthogonal translation systems and genetic code expansion techniques allows for the production of non‑canonical proteins and enzymes that may endow synthetic cells with novel functionalities not present in natural organisms <ref name="Sato2022" />. Additionally, innovations in membrane engineering—ranging from the use of natural phospholipids to robust synthetic polymers and peptide‑based membranes—are expanding the operational range and stability of synthetic cells, making them more suitable for practical applications in harsh or dynamic environments <ref name="Groaz2021" />, <ref name="Elani2018" />. These technological improvements are complemented by computational modeling and agent‑based simulations, which provide predictive frameworks for complex reaction networks and help researchers optimize synthetic cell designs prior to experimental implementation <ref name="Sato2022" />, <ref name="Rothschild2024" />.

=== Points of Inflection and Potential Disruptive Moments ===

The field of synthetic cells is approaching several potential points of inflection. One such inflection point lies in achieving full self‑reproduction and autonomous cell division within synthetic constructs. Despite significant progress, most current synthetic cells require external energy inputs and careful control to sustain metabolic activities; a breakthrough in developing self‑sustaining replication would mark a dramatic shift toward fully "living" synthetic cells <ref name="Sato2022" />. Such progress could trigger a cascade of additional innovations, including open‑ended evolution, whereby synthetic cells could adapt and optimize their functions in response to environmental stimuli <ref name="Rothschild2024" />, <ref name="Devaraj2021" />.

Another potential disruption is the integration of synthetic cells with electronic and digital technologies to create hybrid bioelectronic devices. For instance, coupling synthetic cells with optogenetic control systems or nanostructured sensors could enable real‑time monitoring and precise modulation of cellular functions, opening up novel applications in diagnostics, targeted therapy, and biomanufacturing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />. Such convergence of biotechnology with information technology is likely to generate platforms that are far more responsive and adaptable than current systems.

Furthermore, the ongoing convergence between synthetic biology and materials science may lead to the development of programmable "smart" surfaces and biohybrid materials that incorporate synthetic cells as active elements. These materials could be designed to self‑heal, dynamically respond to economic or environmental stressors, or even mediate communication between disparate biological systems, thereby revolutionizing fields such as regenerative medicine, soft robotics, and environmental remediation <ref name="Rothschild2024" />.

=== Potential "Halo Effects" and Unintended Positive Externalities ===

Beyond their direct applications, synthetic cells have the potential to generate broad societal benefits that extend well beyond their immediate technological impact. For example, the development of robust synthetic cells for biomanufacturing could lead to alternative production platforms for pharmaceuticals, enzymes, and biomaterials that are more sustainable and less resource‑intensive than traditional cell‑based production methods <ref name="Sato2022" />, <ref name="Rothschild2024" />. In the environmental arena, synthetic cells designed for detoxification or pollutant sequestration could contribute to ecosystem remediation efforts by breaking down plastics, heavy metals, or organic contaminants in situ <ref name="Rothschild2024" />.

Moreover, the cross‑disciplinary innovations that underlie synthetic cell technology are likely to have "halo effects" in adjacent fields. Advances in high‑precision microfluidics and membrane engineering, for instance, are directly applicable to the fabrication of nanoscale devices and diagnostic sensors, thereby accelerating progress in nanomedicine and point‑of‑care diagnostics <ref name="Elani2018" />, <ref name="Stano2018" />. In academic settings, the relatively low cost and modularity of synthetic cell systems may inspire a new generation of bioengineers and chemists to explore the fundamentals of life in an open‑source and distributed manner, further democratizing science while fostering innovation in education and research <ref name="Sato2022" />, <ref name="Rothschild2024" />.

In addition, the ethical and regulatory discussions catalyzed by the increasing accessibility of synthetic cell technologies may lead to more robust oversight frameworks that protect public health and the environment while simultaneously encouraging safe innovation <ref name="Sato2022" />, <ref name="Rothschild2024" />. The increased emphasis on biosafety, kill switches, and built‑in containment measures—not only for synthetic cells but for related gene‑editing and synthetic biology applications—has the potential to elevate standards across the board and reduce risk in both industrial and academic settings.

== Summary and Conclusions ==

The field of synthetic cells has demonstrated significant progress across a wide spectrum of applications. Researchers have built platforms that mimic crucial features of natural cells such as compartmentalization, metabolism, gene expression, and communication. In vitro models have enabled precise investigations of biochemical processes, while hybrid systems that interface synthetic cells with natural cells have shown promise in therapeutic, diagnostic, and environmental applications <ref name="Elani2021" />, <ref name="Groaz2021" />, <ref name="Rothschild2024" />. The evolution of biomimetic membranes—from conventional phospholipid vesicles to robust elastin‑like polypeptide and polymersome systems—has broadened the operational envelope of synthetic cells, enabling their use both in controlled laboratory conditions and in more dynamic, open environments <ref name="Groaz2021" />, <ref name="Elani2018" />.

Looking forward, several key innovation trajectories are likely to transform synthetic cell technology. The drive toward achieving autonomous self‑reproduction and complex metabolic integration in synthetic cells represents perhaps the most fundamental challenge, with breakthroughs in these areas promising to create systems that effectively blur the line between non‑living engineered constructs and living organisms <ref name="Sato2022" />. Concurrently, the rapid democratization of biotechnological tools—including low‑cost DNA synthesis and robust cell‑free expression systems—is poised to make the construction of synthetic cells accessible not only to well‑funded laboratories but also to smaller research groups and possibly citizen scientists, a development that will necessitate careful oversight and updated regulatory frameworks <ref name="Rothschild2024" />.

Key drivers of current and future research include advanced microfluidic fabrication techniques, improved membrane engineering and material choices, and enhanced cell‑free systems that support sophisticated gene circuits. These tools provide the means for building increasingly intricate synthetic cells that can serve as platforms in biomedicine, environmental remediation, biomimetic robotics, and sustainable biomanufacturing <ref name="Elani2018" />, <ref name="Stano2018" />, <ref name="Sato2022" />. In addition, the integration of synthetic cells with digital and electronic control systems may give rise to hybrid bioelectronic devices that markedly improve the precision of drug delivery and diagnostic sensing <ref name="Rothschild2024" />, <ref name="VanRaad2021" />.

Moreover, as synthetic cell technology further matures, unintended yet positive externalities are likely to emerge. The same innovations that enable the creation of minimal cell‑like systems could lead to new strategies for ecosystem remediation by deploying synthetic cells that degrade pollutants or sequester heavy metals in contaminated environments <ref name="Rothschild2024" />. In biomanufacturing, synthetic cells may provide scalable and highly controlled platforms for the production of high‑value compounds, reducing reliance on natural organisms that are often constrained by slower growth rates and more complex regulatory networks <ref name="Rothschild2024" />.

Overall, synthetic cell research is advancing along multiple convergent trajectories that are transforming both our understanding of life and the technologies that control biological processes. The integration of multidisciplinary approaches—from materials science and microfluidics to cell‑free synthetic biology and computational modeling—is fostering a rich environment for innovation. Groups such as those led by Adamala, Kamat, Booth, Elani, Liu, Deveraj, and Schwille continue to push the boundaries of what can be achieved with synthetic cells, demonstrating practical applications that span medicine, biotechnology, environmental science, and beyond <ref name="Elani2023">What it means to be alive: a synthetic cell perspective. Yuval Elani, John M. Seddon. Interface Focus (2023). https://doi.org/10.1098/rsfs.2023.0036</ref>, <ref name="Elani2021" />.

In conclusion, the current state of synthetic cell R&D is characterized by stepwise progress in creating well‑defined, functional cell‑mimics that have already provided useful insights into fundamental biological processes and have been applied in a variety of sectors. Looking forward, further integrating metabolic, regulatory, and replicative functions within synthetic cells will likely yield platforms that are increasingly autonomous and life‑like. This will open up transformative applications across drug delivery, biosensing, regenerative medicine, and environmental remediation, while also posing important challenges in governance, safety, and ethical oversight. As costs continue to decline and technical accessibility improves, the democratization of synthetic cell technology promises to unleash a new era of innovation that could have far‑reaching "halo effects" well beyond the confines of synthetic biology itself <ref name="Sato2022" />, <ref name="Rothschild2024" />.

== References ==
<references />

File:Niederholtmeyer-2018.png

2025-08-30T12:24:10Z

Murray: Added link to source

== Summary ==
Communication between cell-mimics via a diffusive genetic activator. Schematic of the two types of cell-mimics communicating through a distributed genetic activation cascade. Micrographs show a merge of brightfield images with rhodamine B fluorescence in the membranes of activators (magenta) and fluorescence of TetR-sfGFP (green) in the hydrogel nuclei of reporters directly after addition of TX-TL and after 2 h of expression.

From: [https://www.nature.com/articles/s41467-018-07473-7 Communication and quorum sensing in non-living mimics of eukaryotic cells]

File:Niederholtmeyer-2018.png

2025-08-30T12:22:38Z

Murray: Added caption

Communication between cell-mimics via a diffusive genetic activator. Schematic of the two types of cell-mimics communicating through a distributed genetic activation cascade. Micrographs show a merge of brightfield images with rhodamine B fluorescence in the membranes of activators (magenta) and fluorescence of TetR-sfGFP (green) in the hydrogel nuclei of reporters directly after addition of TX-TL and after 2 h of expression

File:Niederholtmeyer-2018.png

2025-08-30T12:21:01Z

Murray:

Synthetic cell demonstrations

2025-08-30T12:20:18Z

Murray: /* Communication and Quorum Sensing in Artificial Cells (2018) */

This page provides an overview of synthetic cell demonstrations reported in the scientific literature. The information was generated using a prompt requesting examples of synthetic cell demonstrations from specific research groups, processed by Claude Sonnet 4 on August 29, 2025. The examples focus on bottom-up approaches to creating artificial cellular systems with behaviors that can be incorporated into more complex synthetic cell-based systems.

== Vesicle-based demonstrations ==

This section describes selected examples of synthetic cell-based systems where the compartment is a lipid bilayer vesicle.

=== Engineering Genetic Circuit Interactions Within and Between Synthetic Minimal Cells (2017) ===
[[Image:adamala_syncell.png|400px|thumb|alt={Adamala et al., 2017 Figure 1}|
Overview of genetic circuit interactions within and between synthetic cells. Adamala et al, 2017, Figure 1.]]

Adamala and Boyden demonstrated the first robust example of genetic circuit-based communication between populations of synthetic cells. Their system used liposome-encapsulated genetic circuits that they termed "synells" (synthetic minimal cells). The most sophisticated demonstration involved two distinct populations: sensor synells containing IPTG and genetic circuits to produce α-hemolysin, and reporter synells containing circuits that responded to released signaling molecules (doxycycline and IPTG) by expressing firefly luciferase. The α-hemolysin created pores in membranes, allowing controlled release of signaling molecules and establishing cascaded communication between the two cell populations without crosstalk.

Adamala, K. P., Martin-Alarcon, D. A., Guthrie-Honea, K. R., & Boyden, E. S. (2017). [https://doi.org/10.1038/nchem.2644 Engineering genetic circuit interactions within and between synthetic minimal cells]. Nature Chemistry, 9(5), 431-439.
 

=== Cell-Sized Mechanosensitive and Biosensing Compartment Programmed with DNA (2017) ===

[[Image:liu-2017.png|300px|thumb|alt={Booth et al., 2016, Figure 2}|
Mechanosensitive and biosensing synthetic cell system. Majumder et al., 2017, Figure 4.]]

Liu's group at the University of Michigan, in collaboration with Vincent Noireaux at the University of Minnesota, demonstrated synthetic cells capable of coupling mechanical input to biosensing through genetically programmed components. The system used liposomes containing cell-free transcription-translation (TX-TL) reactions that expressed two key proteins: the E. coli mechanosensitive channel of large conductance (MscL) and the calcium biosensor G-GECO. They showed that osmotic pressure changes could activate MscL channels in the synthetic cell membrane, allowing calcium influx that was detected by the co-expressed G-GECO protein through a 23-26 fold increase in fluorescence.

Majumder, S., Garamella, J., Wang, Y. L., DeNies, M., Noireaux, V., & Liu, A. P. (2017). [https://doi.org/10.1039/C7CC03455E Cell-sized mechanosensitive and biosensing compartment programmed with DNA]. Chemical Communications, 53(53), 7349-7352.
 

=== Controlling Secretion in Artificial Cells with a Membrane AND Gate (2019) ===
[[Image:Kamat-2019.jpg|thumb|300px|Schematic of a membrane AND gate. Hilburger et al., 2019, Figure 1.]]

Kamat's group at Northwestern developed artificial cells capable of controlled secretion using a membrane-based AND gate that implements Boolean logic through membrane composition changes. The system used giant unilamellar vesicles containing α-hemolysin protein and required both oleic acid (fatty acid) AND the pore-forming protein to achieve cargo release. The key innovation was controlling when α-hemolysin could functionally assemble into membrane pores based on membrane lipid composition. Initially, vesicles with low oleic acid content prevented α-hemolysin from assembling into functional pores, keeping the membrane impermeable. However, when oleic acid micelles were added externally, they incorporated into the vesicle membrane, changing its composition to enable α-hemolysin assembly into functional heptameric channels. This membrane transformation triggered the release of encapsulated cargo such as calcein. The system demonstrated that membrane-based Boolean logic could complement genetic circuits and provided a new method for temporal control of vesicle permeability through membrane protein-lipid interactions.

Hilburger, C. E., Jacobs, M. L., Lewis, K. R., Peruzzi, J. A., & Kamat, N. P. (2019). [https://doi.org/10.1021/acssynbio.8b00435 Controlling secretion in artificial cells with a membrane AND gate]. ACS Synthetic Biology, 8(6), 1224-1230.
 

=== TXTL-Based Synthetic Cell Systems (2021) ===
[[Image:Noireaux-20121.jpg|thumb|400px|Cell-free expression and synthesis of deGFP in synthetic cells.. Garenne et al., 2021, Figure 4.]]

Noireaux's group developed the all-E. coli TXTL toolbox 3.0 for creating synthetic cell prototypes using cell-free transcription-translation systems. The most sophisticated demonstration involved semi-continuous synthetic cells where liposomes loaded with TXTL reactions could produce enhanced green fluorescent protein (eGFP) at concentrations exceeding 8 mg/ml. This was achieved by allowing chemical building blocks to diffuse through membrane channels, creating a feeding mechanism that sustained protein synthesis over extended periods. The system also demonstrated the synthesis of complex biological entities, including the complete bacteriophage T7 (40 kb genome, ~60 genes) at concentrations of 10^13 PFU/ml.

Garenne, D., Thompson, S., Brisson, A., Khakimzhan, A., & Noireaux, V. (2021). [https://doi.org/10.1093/synbio/ysab017 The all-E. coli TXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform]. Synthetic Biology, 6(1), ysab017.
 

=== Biomimetic Behaviours in Hydrogel Artificial Cells through Embedded Organelles (2023) ===

[[Image:elani-2023.jpg|400px|thumb|alt={Allen et al., 2013, Figure 1}|
Design and function of the hydrogel artificial cells.. Allen et al., 2023 Figure 1.]]

Elani's group at Imperial College developed a microfluidic strategy to create biocompatible cell-sized hydrogel-based artificial cells with embedded functional subcompartments acting as engineered synthetic organelles. They demonstrated artificial cells capable of multiple biomimetic behaviors through modular, interchangeable subcompartments. The system included magnetic particles as "motility organelles" that enabled stimulus-induced movement when exposed to magnetic fields, and lipid vesicle organelles containing encapsulated cargo that could be released in response to specific enzymatic biomarkers. For example, vesicles containing β-galactosidase substrate were embedded within the hydrogel matrix, and when the enzyme was present in the environment, it triggered controlled release of the vesicle contents. The artificial cells also demonstrated enzymatic communication with surrounding bioinspired compartments through cascaded biochemical reactions. This work represents a demonstration of hydrogel-based artificial cells with multiple types of synthetic organelles that could replicate complex cellular behaviors including motility, sensing, content release, and intercellular communication within a single synthetic cell chassis.

Allen, M. E., Hindley, J. W., O'Toole, N., Cooke, H. S., Contini, C., Law, R. V., ... & Elani, Y. (2023). [https://doi.org/10.1073/pnas.2307772120 Biomimetic behaviours in hydrogel artificial cells through embedded organelles]. Proceedings of the National Academy of Sciences, 120(35), e2307772120.
 

=== Self-Organized Spatial Targeting of Contractile Actomyosin Rings for Synthetic Cell Division (2024) ===
[[Image:Schwille-actomyosin-2024.png|thumb|400px|Co-reconstitution of actomyosin networks and the MinDE system enables the reorganization and positioning of actomyosin bundles at mid-cell. Reverte-López et al., 2024, Figure 1.]]

Schwille's group at the Max Planck Institute were able to implement synthetic cell division by successfully combining eukaryotic actomyosin contractile machinery with the bacterial MinDE protein positioning system. The most sophisticated demonstration showed giant unilamellar vesicles containing actomyosin rings that were spatiotemporally positioned at the vesicle equator by MinDE pole-to-pole oscillations through a diffusiophoretic transport mechanism. The MinDE system created active transport of the membrane-bound actomyosin structures via frictional forces, accumulating them at mid-cell in an orientation perpendicular to the oscillation axis. The positioned contractile rings then generated sustained furrow-like membrane invaginations, breaking the spherical symmetry and creating two-lobed vesicles while maintaining the spatial organization. This work represented the first successful integration of spatial positioning machinery with contractile elements to achieve controlled membrane constriction at defined locations, addressing one of the key challenges in synthetic cell division.

Reverte-López, M., Kanwa, N., Qutbuddin, Y., et al. (2024). [https://doi.org/10.1038/s41467-024-54807-9 Self-organized spatial targeting of contractile actomyosin rings for synthetic cell division]. Nature Communications, 15, 10415.
 

== Other compartmentalization techniques ==

This section describes selected examples of systems where the compartment is something other than a lipid bilayer-based vesicle.

=== Light-Activated Communication in Synthetic Tissues (2016) ===

[[Image:booth-2016.jpg|400px|thumb|alt={Booth et al., 2016, Figure 2}|
Light-activated expression of LA-mVenus in synthetic cells and synthetic tissues. Booth et al., 2016 Figure 2.]]

Booth and colleagues developed one of the earliest demonstrations of communication between droplet-based synthetic cells using light-activated control systems. The system involved 3D-printing droplets containing PURE cell-free transcription-translation (TX-TL) systems that could produce α-hemolysin pore proteins upon light activation. When these pore proteins were incorporated into specific bilayer interfaces, they mediated rapid, directional electrical communication between subsets of artificial cells, mimicking neural transmission in living tissue. The light activation provided precise spatial and temporal control over which cells could communicate, creating the first demonstration of tissue-like organization in synthetic cell systems.

Booth, M. J., Schild, V. R., Graham, A. D., Olof, S. N., & Bayley, H. (2016). [https://doi.org/10.1126/sciadv.1600056 Light-activated communication in synthetic tissues]. Science Advances, 2(4), e1600056.
 

=== Communication and Quorum Sensing in Artificial Cells (2018) ===
[[Image:Niederholtmeyer-2018.png|thumb|300px|Communication between cell-mimics via a diffusive genetic activator. Niederholtmeyer et al., 2018, Figure 3.]]

Devaraj’s group at UC San Diego developed artificial cells capable of chemical communication using quorum-sensing genetic circuits encapsulated inside a porous polymer membrane containing an artificial hydrogel compartment. "Activator" synthetic cells produced T3 RNAP, which diffused through the polymer membrane into "detector" synthetic cells that expressed GFP. The system demonstrated that non-living vesicle-based mimics could exchange information through diffusible signaling molecules, allowing one population of artificial cells to regulate gene expression in another. This work provided a demonstrations of intercellular communication between synthetic cells and highlighted the potential of quorum sensing as a design principle for coordinating behavior in cell-free systems.

Niederholtmeyer, H., Chaggan, C., & Devaraj, N. K. (2018). [https://doi.org/10.1038/s41467-018-07473-7 Communication and quorum sensing in non-living mimics of eukaryotic cells]. Nature Communications, 9, 5027.
 

=== DNA-Based Communication in Populations of Synthetic Protocells (2019) ===
[[File:Joesaar-2019.png|thumb|400px|PCompartmentalized DNA-based Boolean logic circuits. Joesaar et al, 2019, Figure 5.]]

Joesaar, Mann, de Greef and colleagues developed a highly sophisticated platform called "biomolecular implementation of protocellular communication" (BIO-PC) using proteinosomes as artificial cell chassis. The system leveraged enzyme-free DNA strand-displacement circuits encapsulated within semipermeable protein-polymer microcapsules. The most complex demonstration showed bidirectional communication and distributed computational operations, where protocells could sense DNA-based input messages, process them through programmable logic circuits, and secrete output DNA strands that activated neighboring protocells. The encapsulation protected the DNA circuits from nuclease degradation, allowing operation in concentrated serum conditions.

Joesaar, A., Yang, S., Bögels, B., van der Linden, A., Pieters, P., Kumar, B. V. V. S. P., ... & de Greef, T. F. A. (2019). [https://doi.org/10.1038/s41565-019-0399-9 DNA-based communication in populations of synthetic protocells]. Nature Nanotechnology, 14(4), 369-378.